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Abstract 
 
Cognitive and Physical Performance in Patients with Asymptomatic Carotid Artery Stenosis and 
Occlusion. 
This dissertation project presents a review of the anatomy and functional relationships of the 
circulatory territory of the internal carotid artery, and considers the functional changes that can 
occur when there is disease within this system.  The project has two specific aims which are 
addressed in two articles.  The first specific aim is to determine if persons with asymptomatic 
carotid artery disease (high moderate stenosis through occlusion) demonstrate deficits in 
cognition and on physical performance measures.  The second specific aim is to determine if 
there is a correlation between the cognitive measures and the instrumental activities of daily 
living in these asymptomatic patients. 
 
In the first article, the purpose of the study was to determine if patients with asymptomatic 
carotid artery stenosis and occlusion demonstrate deficits in cognitive and physical performance.  
The relationship between cognitive measures and performance of instrumental activities of daily 
living was examined.  Thirty-nine patients with asymptomatic carotid artery stenosis of moderate 
and severe degrees, or occlusion were tested.  Cognition was assessed via the Repeatable Battery 
for the Assessment of Neuropsychological Status (RBANS) and the Executive Interview (EXIT).  
Physical performance was assessed via the Physical Performance Test (PPT), and the Lawton 
Instrumental Activities of Daily Living.  Deficits in cognitive function were found on the 
RBANS for all levels of stenosis and occluded subgroups in the domains of 
visuospatial/constructional and delayed memory, in the moderate stenosis subgroup in immediate 
memory, attention and visuospatial/constructional, and in the severe subgroup in all domains 
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except language.  There were no significant findings on the EXIT.  Decreased performance on 
the PPT was identified in all 3 subgroups.  The Lawton IADL did not identify any decrease in 
IADL performance. 
 
The second article included a more definitive examination of physical performance.   Physical 
performance was assessed via the 9-item and 7-item Physical Performance Test (PPT).  
Individual tasks were also timed.  Patients with asymptomatic carotid artery stenosis and 
occlusion demonstrated less than optimal performance on the PPT ( 9-item, 27/36; 7-item 21/28).  
Simulated eating was the slowest task to perform for the patients with moderate stenosis.   
 
Deficits in cognitive function were found in this observational study of patients with 
asymptomatic carotid artery stenosis and occlusion. Additionally, patients exhibited changes in 
function as indicated by their performance on the PPT.  This may be indicative of preclinical 
disability, and a potential symptomatic status of the patient.  Both articles demonstrate that 
asymptomatic patients may not be truly asymptomatic.  This potential change in status needs to 
be considered as patients are being evaluated for interventions to manage their carotid artery 
disease.  
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I.  Introduction 
 
Stroke is a major health care problem in the United States with an annual incidence of more than 
700,000, and is the leading cause of adult disability amongst Americans.1,2  Stroke prevention 
has become a major concern in health care.  One population that has been identified as persons at 
possible risk for stroke is persons with carotid artery disease, stenosis and occlusion.  Persons 
with carotid artery disease are described as being symptomatic or asymptomatic.  However, in 
the case of asymptomatic persons, the question has been raised as to whether persons with 
asymptomatic carotid artery stenosis and occlusion truly are asymptomatic. Often discovered as 
an incidental finding, persons with carotid artery disease who claim to be asymptomatic may 
actually be unaware of or in denial of their possible symptoms.  This problem has led to the 
question that is the focus of this dissertation project, which is to determine if asymptomatic 
persons with stenotic or occluded carotid arteries are truly asymptomatic.    
 
After observing patients with carotid artery disease in the neurosurgery clinic at the University of 
Pittsburgh over the last two years, it has been noted that many patients with carotid artery 
stenosis and occlusion have impairments.  Significant others of the person and clinical 
examination have revealed that the persons with symptomatic and asymptomatic carotid artery 
disease are experiencing symptoms which may serve as warning signs of a potential stroke, such 
as brief periods of confusion, word-finding difficulties, and forgetfulness. There is some 
controversy about the neurosurgical management of at least a subgroup of these symptomatic 
occluded persons, who are believed to have hemodynamically compromised cerebral blood flow 
depending upon the physiology of their carotid artery occlusion.3-6 
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In this project, in asymptomatic moderately and severely stenotic, and occluded persons, an 
attempt will be made to take a detailed look at the person’s function in both the cognitive and the 
physical domains.  Some of the subtle changes that may be occurring in persons with carotid 
artery disease may be detected through inexpensive and noninvasive assessments of cognitive 
and physical functioning.  Also, the relationship between the patient’s cognitive performance and 
ability to complete instrumental activities of daily living will be examined.  Data about the 
persons cognition and physical functioning will aid in planning future care of the patient based 
on the presence of any impairments noted that might be influencing the person’s quality of life.  
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II.  Statement of the Problem 
There is one study available that reports cognitive function only,7 and no study that reports 
physical function of asymptomatic patients with carotid artery stenosis and occlusion.  In 
asymptomatic patients with stenosis, the stroke risk has been observed to be relatively low.8,9  
However, there is an increase in the risk of stroke when the degree of stenosis is more severe.10  
Additionally, it is controversial as to whether asymptomatic patients with carotid artery 
occlusion are at risk for stroke.11-15  However, if there is reason to believe that asymptomatic 
patients are really not asymptomatic, then a low stroke risk may not be an accurate prediction for 
some patients.  In a related patient population who are considered at risk for stroke (patients with 
asymptomatic cerebral aneurysms) Weibers et.al. identifies that asymptomatic patients 
demonstrate impaired mental status on a Mini-Mental State Examination or a Telephone 
Interview for Cognitive Status, both of which indicated a serious cognitive abnormality at  30 
day and one year follow-ups.16 This was the first time that deficits with supposedly 
asymptomatic patients with aneurysms were documented.  It is suspected that patients with 
asymptomatic carotid artery disease may show a similar presence of undetected deficits.  
Therefore the purpose of this research project is to perform a more detailed assessment of 
cognitive and physical functional abilities in the patient with asymptomatic moderate or severe 
carotid artery stenosis and occlusion.  The second part of the project will consider the 
relationship between the patients’ cognitive function and their ability to perform instrumental 
activities of daily living.  Cognitive skills from six cognitive domains and physical functional 
performance will be assessed. 
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The following sections will describe: 1) the carotid circulation to the brain and its branches, 2) 
the relationships of the circulation to the anatomy of the brain and the functions associated with 
these regions, 3) the pathology of carotid artery disease including both carotid artery stenosis and 
occlusion, 4) the characteristics of patients with asymptomatic and symptomatic carotid artery 
stenosis and occlusion and their risk for stroke, and 5) the assessment tools chosen to use for the 
evaluation of cognitive and physical function in patients with asymptomatic carotid artery 
stenosis and occlusion.  
2.1.  The Circulation of the Carotid Artery System 
The circulation to the brain consists of a network of arteries developed to feed the anterior and 
the posterior portions of the brain.  The internal carotid artery (ICA) is the primary blood supply 
to the anterior brain circulation.  ( Figure 1) 
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Figure 1:  Circulation of the Internal Carotid Artery.  
Modified from: [Netter FH: Atlas of Human Anatomy, 2nd ed., East Hanover, New Jersey, 1997, 
Novartis, Netter illustrations used with permission from Icon Learning Systems, a division of 
MediMedia USA, Inc.  All rights reserved.] 
 
The internal carotid artery and the external carotid artery branch off from the common carotid 
artery in the neck.   This artery enters the brain through the carotid canal in the petrous portion of 
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the temporal bone in the bottom of the skull.  The cerebral segment of the ICA terminates into 
the middle cerebral artery (MCA) and the anterior cerebral artery (ACA), and also gives off the 
major branches of the opthalmic artery, superior hypophysial artery, the posterior 
communicating artery and the anterior choriodal artery.17  (Figure 1) 
 
In some situations, the posterior cerebral artery will be derived from the ICA, coming off an enlarged 
posterior communicating artery, however this is not typical.18  The branching arteries and corresponding 
areas of the brain that receive blood supply from these main ICA branches (Figure 2) include the:  
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Figure 2:  Portions of the Brain Supplied by the Anterior, Middle and Posterior Cerebral 
Arteries. 
(Anterior – Green, Middle – Purple, Posterior – Yellow) [From Moore KL, Dalley AF: clinically 
oriented Anatomy 4th ed., Baltimore, 1999, Lippincott Williams and Wilkens, with permission] 
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• Anterior Cerebral Artery (ACA) – The medial surface of the cerebrum, superior border of 
the frontal and parietal lobes. 
• Middle Cerebral Artery (MCA) – Most of the lateral surface of the cerebral hemispheres 
including the lateral frontal lobe, temporal lobe – superior and lateral portions, and the 
deep structures of the frontal and parietal lobes. 
• Posterior Cerebral Artery (PCA) (not typically) – The occipital lobe and inferior and 
medial portions of the temporal lobe. 
Also important to the blood supply to the brain are the lenticulostriate arteries, which are 
penetrating branches from the larger cerebral arteries, and supply the basal ganglion and internal 
capsule.18  The perforating branches of the posterior cerebral artery supply the thalamus.18 
2.2.  Anatomic and Functional Relationships 
There has been evidence accumulating in the cerebrovascular literature that in patients with 
carotid artery disease, a transient ischemic attack (TIA) or a stroke can occur.  In cases of carotid 
artery stenosis and occlusion, this may be due to either 1) an embolus formation in an artery that 
would disrupt blood flow in the distal artery, or 2) compromised hemodynamic cerebral blood 
flow.3-6,19-24  Currently, these investigations are being preformed from a physiologic perspective 
with the evaluation and measurement of cerebral blood flow through technology such as positron 
emission tomography (PET), single-photon emission CT, transcranial doppler studies, or stable 
Xenon CT.22 The outcome measures in many of these studies consist solely of the occurrence of 
a TIA or a stroke.3,5,21,25,26  At the present time there is one article in the literature that addresses 
how patients with asymptomatic carotid artery disease function from a cognitive perspective.7  
The researchers concluded that cognitive dysfunction is more common in patients with severe 
stenosis affecting the left carotid artery.7  No documentation of function of asymptomatic 
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persons with carotid artery disease from the physical perspective has been found.  It is important 
to relate the areas of the brain that may be demonstrating a disruption of blood flow due to the 
carotid artery disease, and the functional attributes of these areas, with the patient’s actual 
functional performance.  Figure 3 describes these relationships: 
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Figure 3:  Relationships of Blood Supply, Brain Area and Function17 
ARTERY BRAIN TISSUE 
SUPPLIED 
FUNCTION OF THIS AREA 
ANTERIOR 
CEREBRAL 
ARTERY 
Medial surface of 
the cerebrum 
 
 
 
 
 
Superior border of 
the parietal and  
frontal lobes 
Frontal lobe- Discrete lower extremity movements, 
gross movements, emotions 
Parietal lobe – Somatosensory localization lower 
extremity 
Temporal lobe-Fear/anxiety; short-term memory 
Occipital Lobe – Contralateral visual field 
 
Proximal lower extremity and trunk voluntary 
movements and sensation 
MIDDLE 
CEREBRAL  
ARTERY 
Lateral frontal and 
temporal lobes 
 
 
 
Superior temporal 
lobe 
 
Deep frontal and 
parietal lobe 
Frontal lobe – Discrete voluntary movements, eye 
movements, motivation, planning, judgement 
Temporal lobe – Long term memory 
 
 
Bilateral hearing and possibly new memory 
 
 
Language production, taste, discrete voluntary 
movements of the jaw, mouth and tongue, 
somesthetic sensations 
POSTERIOR 
CEREBRAL 
ARTERY 
Occipital lobe 
 
Inferior and medial 
temporal lobe 
Vision and visual association 
 
Emotions, behavior and memory 
 
Clearly cognitive function and motor and sensory physical function may be in jeopardy in 
patients that have jeopardized cerebral circulation from carotid artery disease.  It is the intent of 
this dissertation project to evaluate patients with asymptomatic carotid artery moderate and 
severe stenosis and occlusion based on their functional abilities with respect to the cortical areas 
served by the main internal carotid artery branches, in particular, the anterior cerebral artery and 
the middle cerebral artery.  Therefore cognitive measures that will screen patients for deficits in 
the domains of short-term memory, long term memory, attention, language, problem-solving, 
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and association functions of visuospatial/constructional nature are included in the screening.  
This project will determine if these functions are intact or if there are deficits.  If there are 
identified deficits, then to determine if there is a relationship between the deficit and the amount 
of carotid artery disease (moderate stenosis, severe stenosis, or occlusion) is of interest.  
Additionally, a relationship between the side of the carotid artery disease and the domain of 
cognitive deficit is of interest, since some of the cognitive functions are attributed to one side of 
the brain more than the other.27  For example, language is primarily mediated via the left cerebral 
hemisphere, and attention and visuospatial/ constructional functions are more attributed to the 
right hemisphere.27 Additionally, physical measures that parallel activities that are important in 
daily life will be tested to assess physical function.  Also, performance on the instrumental 
activities of daily living, such as taking medications, meal preparation, and answering the phone 
will be compared to the individual’s cognitive function.  
2.3.  Carotid Artery Disease 
The pathology behind carotid artery stenosis, which can lead to occlusion, is injury to the artery 
wall, especially the intima, due to the process of atherogenesis.  During this process there is focal 
injury to the vessel wall with a breakdown of the connective tissue surface.  This breakdown 
stimulates blood platelets to aggregate inside the arterial wall.  During this, there is a release of 
certain substances including lipids that will induce endothelial cell proliferation and form a 
fibrous plaque that protrudes into and can completely block the blood vessel lumen. (Figure 4) 
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Figure 4:  Occluded Carotid Artery. 
[From Moore KL, Dalley AF: clinically oriented Anatomy, 4th ed.,Baltimore, 1999, Lippincott 
Williams and Wilkens, with permission] 
 
Atherosclerotic plaque is most commonly found in the neck immediately after the bifurcation of 
the external and internal carotid arteries in the proximal portion of the internal carotid artery 
(ICA).18  The other places where this atherosclerotic plaque is most frequently found include the 
proximal (near the point of exit from the ICA) middle cerebral artery, and within the vertebral 
and basilar arteries.18  In arteries that are partially occluded, or stenotic, the atherosclerotic lesion 
can release emboli that can lodge in the distal arteries on the same side, resulting in a “carotid 
artery” ischemic stroke.28 (Figure 5) 
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Figure 5:  Ulcerated plaque removed from a patient with an asymptomatic carotid artery. 
[Courtesy of Dr. Howard Yonas, Department of Neurosurgery, University of Pittsburgh Medical 
Center, with permission] 
A second complicating factor that places patients with stenosis at risk for stroke is the 
progression of stenosis to complete occlusion.29  The result of decreased blood flow to brain 
tissue distal to this blockage in the artery can also lead to cerebral infarction by way of two 
proposed mechanisms; embolic sources, and hemodynamic compromise. 
 
Blaser et. al followed patients with severe carotid artery stenosis who were symptomatic and 
scheduled for carotid endararectomy to determine parameters predictive of stroke recurrence, or 
carotid artery occlusion prior to the scheduled surgery.30 They found that exhausted 
cerebrovascular reactivity as determined by a Doppler CO2 test of the middle cerebral artery was 
predictive of disabling stroke in these patients with stenosis.  Also, 12 of the 120 patients 
experienced progression of the stenosis to occlusion of the artery.  However, in the absence of 
hemodynamic compromise of blood flow, occlusion was not associated with increased stroke 
risk.30  Similar conclusions were drawn by Markus and Cullinane, who in patients with 
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hemodynamic compromise, found risk for stroke in patients with carotid occlusion (6 %/year), 
and risk to a lesser extent in patients with severe asymptomatic carotid stenosis (1%/year).24 
2.3.1.  Symptomatic Carotid Artery Disease: 
 
Transient Ischemic Attack (TIA) – The Common Symptom 
In both disease processes of carotid artery stenosis and occlusion, a common symptom is 
recognized, the transient ischemic attack (TIA). The TIA, occurring in the carotid-middle 
cerebral artery territory, has been described with the most common symptoms of weakness, 
paralysis, numbness, tingling or heaviness, which tend to involve the opposite arm or leg or half 
of the face.  It has been documented in symptomatic carotid disease that 40% of the cases will 
have monocular blindness.31  Monocular blindness is described by patients as a gray-black shade 
or curtain that comes down over the eye, a fog, blur, or blindness in one eye.32  The symptoms of 
a TIA are to last less than 24 hours and then resolve.31  However, a revised definition has been 
proposed that suggests that a TIA is a brief episode of neurologic dysfunction with clinical 
symptoms that should last less than 1 hour with no acute infarction visible on imaging.33 
 
As previously mentioned, in cases of carotid artery stenosis and occlusion the source of the TIA 
has been proposed to be from an embolic source, or due to hemodynamic compromise of the 
blood flow.22,29,32,34-37  In a study by Pessin and others, the investigators identified that patients 
with both open carotid artery lumens (> 2mm) and tight carotid artery lumens (< 2mm or 
occluded) experience TIA’s which included pure hemispheric symptoms, pure monocular 
blindness, or a combination of the two symptoms experienced separately from one another.32  
The mechanisms proposed by the authors for TIA’s in this situation included:  1) cerebral 
embolism, 2) lacunar disease, and 3) transient carotid occlusion.32  Barnett et. al. studied nine 
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patients with carotid artery occlusion and determined that that their TIA’s were a result of 
thromboembolism from the stump of the ipsilateral occluded carotid artery.38  Embolic events 
causing symptoms have also been found in cases of carotid artery occlusion on one side and 
stenosis on the other side.35 In these patients the investigators have recommended that carotid 
endarterectomy of the stenotic side may reduce the passage of the emboli from one cerebral 
hemisphere to the other and potentially reduce the risk of stroke.35  
 
The hemodynamic explanation for the incidence of TIA’s has also been suggested in cases of 
carotid artery stenosis and occlusion.22,24,36,37,39,40  However in this situation, the symptoms have 
some potentially different manifestations.  The most common different characteristic is described 
as limb shaking.31,36,37,39,40  Limb shaking is a rhythmic involuntary movement of one or both 
extremities on the side opposite the pathologic carotid artery.  The attacks are brief, and can 
resemble simpler focal motor seizures.  In these patients, the compromised cerebral blood flow to 
the brain can be measured by positron emission tomography (PET), transcranial doppler, single-
photon emission CT, or stable Xenon CT.22,36,41-45  Klijn et.al found that venous stasis 
retinopathy (VSR) was another common symptom associated with a hemodynamic cause of 
decreased blood flow to the opthalmic artery (a branch of the internal carotid artery) in patients 
with symptomatic carotid artery occlusion.46  In this study, one third of the 110 patients studied 
with carotid artery occlusion experienced monocular blindness.  The researchers concluded that 
VSR is associated with an impaired blood flow state to the brain.46 
 
In 1999, the American Heart Association Stroke Council published a supplement to The 
Guidelines for the Management of Transient Ischemic Attacks.47  In this document, 
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recommendations are outlined for the management of TIA’s based on the latest medical 
evidence, with stroke prevention as the ultimate goal of the guidelines.  The recommendations 
include:  a) risk factor management, b) medical therapy, and  c) surgical management.  Within 
this document, the management of TIA’s in patients with either carotid artery stenosis or carotid 
artery occlusion is discussed.47 
2.3.2.  Carotid Artery Stenosis - Symptomatic 
Carotid endarterectomy (CEA) is now recognized as the “gold standard” for management of 
clinically significant carotid artery stenotic disease.28,48,49  Clinical significance is the presence of 
symptoms such as the TIA previously discussed, retinal infarction, or a non-disabling ischemic 
stroke.28  Clinical significance is also determined by the amount of stenosis of the internal carotid 
artery. In two landmark studies, the MRC European Carotid Surgery Trial, and the North 
American Symptomatic Carotid Endarterectomy Trial, arterial stenosis of 0-29% was considered 
mild, 30-49% low moderate,  50-69% high moderate and 70-99% severe.28,49  In the case of mild 
and low moderate stenosis, the early risks of surgery outweighed any benefit over a 3-year 
follow-up, and surgical intervention is not a typically recommended course of treatment.49  In  
high moderate stenosis, the recommendations have not been as clear.  However, recent research 
on this population has shown that there is benefit of carotid endarterectomy surgery over medical 
management in the reduction of ipsilateral stroke rate followed for 5 years with a 22% medically 
managed group rate versus 16% CEA rate after 8 years of follow-up.48,50,51  In severe stenotic 
cases, the risk of carotid endarterectomy surgery was significantly outweighed by the benefit of a 
reduced risk of stroke in the patients, a sixfold reduction in the European Carotid Surgery Trial, 
and a 17% risk reduction in the North American Symptomatic Carotid Endarterectomy Trial.28,49 
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2.3.3.  Carotid Artery Stenosis – Asymptomatic 
In asymptomatic carotid artery stenosis, the stroke risk has been found to be relatively low, and 
related to the degree of carotid artery stenosis.8,10  Autret et.al. followed 242 patients with no 
neurological symptoms and carotid stenosis for an average of 29.4 months using an occurrence 
of a TIA or a stroke as the endpoint.  The researchers concluded that patients with 0-50% 
stenosis had a crude annual stroke risk of .23%, in patients with 50-75% stenosis the crude 
annual stroke risk was 2.48%, and in patients with 75-99% stenosis, the risk was 1.71%.  The 
researchers did not consider any of these findings to delineate a group of asymptomatic stenotic 
patients to have a major risk of stroke.8  Norris et.al. also identified stroke risk in asymptomatic 
patients with varying degrees of carotid stenosis.  In patients with stenosis ≤ 75%, the 
researchers concluded that risk was negligible (1.3%), and in patients with > 75% stenosis, there 
was an ipsilateral stroke risk of 2.5%.10  In the patients with the more severe stenosis, the 
researchers recommended that consideration of a carotid endarterectomy for stroke prevention be 
considered.10   
 
More recent research by Benevente et.al. has concluded that in asymptomatic carotid artery 
stenosis the reduction of ipsilateral stroke risk via CEA still occurs, however the risk reduction is 
relatively small.52  The authors of the Asymptomatic Carotid Artery Study (ACAS) do, however, 
conclude that in asymptomatic carotid artery disease of 60% stenosis or more, that carotid 
endarterectomy surgery in patients with good general health can help to decrease a 5-year risk of 
ipsilateral stroke by 53%.19  In asymptomatic patients with carotid artery stenosis, the physician 
needs to consider a myriad of factors in weighing the benefit of surgical treatment versus 
medical intervention.  These factors include the patient’s age, gender, general health, and degree 
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of stenosis.  In high grade (>90%) asymptomatic carotid artery stenosis, the procedure of a 
carotid endarterectomy has been the intervention of choice.53  This may be due to the increased 
risk of stroke as stenosis progresses to occlusion. 
 
In 1995, the American Heart Association published a Medical/ Scientific Statement as a Special 
Report: Guidelines for Carotid Endarterectomy; A Multidisciplinary Consensus Statement From 
the Ad Hoc Committee, American Heart Association.54  In this statement, the indications for 
carotid endarterectomy in symptomatic good-risk patients, and asymptomatic good-risk patients 
are enumerated.54  It is advised that this statement be a driving force in the clinical decision 
making of the physician regarding patients with carotid artery stenosis considering carotid 
endarterectomy as a possible intervention for management.  
2.3.4.  Carotid Artery Occlusion - Symptomatic 
The incidence of stroke in a patient with symptomatic carotid artery occlusion has been 
documented in the literature.  In a summary of twelve prospective follow-up studies of 
symptomatic patients with carotid artery occlusion, Hankey and Warlow documented an overall 
subsequent stroke risk of 7% per year, and a 6% risk of stroke on the ipsilateral side of the 
occluded carotid artery.55  The risk of stroke persists despite medical treatment with platelet-
inhibiting and anticoagulation medications that are the attention of current medical and 
neurosurgical research.23  There has also been the resurgence of the question of the viability of 
extracranial-intracranial (EC/IC) arterial bypass surgery for the prevention of stroke.23  
Extracranial-intracranial bypass surgery had been the standard of care in patients with 
symptomatic carotid artery occlusion until 1985, when an international multi-center study 
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concluded that the bypass of the superficial temporal artery to the middle cerebral artery was not 
effective in subsequent stroke prevention in these patients.56  
 
Over the last decade or so, there has been ongoing discussion as to the appropriateness of this 
decision to abandon the EC/IC arterial bypass surgery.  There has been the identification of a 
subgroup of patients with carotid artery occlusion who may be viable candidates to benefit from 
this surgery for the prevention of a subsequent stroke.4,22,57  However, it is yet unproven as to the 
long term outcomes of using impaired cerebral hemodynamics to identify this subgroup and 
select possible candidates for this procedure.23  One of the first identifying factors of a patient 
who belongs in this subgroup of patients with hemodynamic compromise comes from the history 
and clinical examination.  There are a characteristic set of symptoms that describes these patients 
with symptomatic carotid artery occlusion who may fall into this subgroup with reduced cerebral 
blood flow.36,37,39,40  One distinguishing symptom is “limb-shaking” which typically occurs with 
a change in position toward upright; this causing a drop in blood pressure.37,39,40  Other findings 
are typically described as a transient ischemic attack (TIA) and may include transient monocular 
blindness (blindness in one or both eyes described as a shade coming down over the eyes), 
weakness of an arm or leg, numbness of an arm or leg, slurred speech, and possibly 
aphasia.31,32,39  Appropriately, these symptoms are related to the functional areas of the brain 
which receive their blood supply from the major branches of the internal carotid artery already 
discussed. 
2.3.5.  Carotid Artery Occlusion - Asymptomatic 
The prognosis of a patient with asymptomatic (never symptomatic) carotid artery occlusion 
remains controversial in the literature.  Hennerici et al. prospectively followed 49 patients with 
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carotid artery occlusion for an average of 31.2 months.  These patients were asymptomatic 
without any neurological signs or symptoms.  The outcome measures of death, recurrent TIA, 
and stroke when assessed revealed a 16% stroke rate, 10% TIA rate, and 47 % death rate during 
follow up.  Death was primarily due to coronary artery disease.  The authors concluded that 
patients with asymptomatic carotid artery occlusion are at considerable risk to experience a 
stroke.11  Nicholls and colleagues found a 31% stroke risk in patients with asymptomatic carotid 
artery occlusion within the first year after the occlusion.14 
 
In contrast, Bornstein and Norris followed 40 patients with unilateral carotid occlusion for two 
years.12  None of the patients with an occluded carotid artery experienced a stroke. The authors 
concluded that the asymptomatic patients with carotid artery occlusion have a benign outcome.  
It was suggested that collateral blood supply is adequate to substitute for the occluded carotid 
artery.12  This collateral blood supply comes from the opposite carotid artery by way of the circle 
of Willis, through retrograde flow of the ipsilateral opthalmic artery, and through leptomeningeal 
collaterals.4,22,23 
 
In a later study of 30 never symptomatic and 81 symptomatic patients with carotid artery 
occlusion, it was concluded that the never symptomatic carotid occlusion group carried an 
inappreciable stroke risk.13  One of the 30 asymptomatic patients experienced an ischemic stroke 
(3%).  The rationale offered for the benign prognosis of these patients is the low incidence of 
cerebral hemodynamic compromise due to collateral blood supply.13  This low incidence of 
hemodynamic compromise was documented in symptomatic and asymptomatic patients by 
Derdeyn et al. in a study measuring the oxygen extraction fraction (OEF), or “misery perfusion” 
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in patients with carotid occlusion.4  In this study five of thirty-six asymptomatic patients 
demonstrated an increased OEF (14 %), while thirty-nine of eighty-one (48 %) symptomatic 
patients demonstrated an increased OEF.4  While this difference was significant between the two 
groups, and the asymptomatic group appears much less likely to demonstrate misery perfusion, it 
seems as though the 14% of asymptomatic patients that were found to demonstrate cerebral 
hemodynamic compromise still deserve attention for stroke prevention. 
 
An asymptomatic patient is often discovered as an incidental finding due to other medical 
procedures or work-up.  Therefore, some of the people with an occluded carotid artery may 
proceed to having a potentially preventable stroke if there was a mechanism to identify this 
problem beforehand. There may be subtle changes in function not recognized by the patient in 
the areas of thinking, memory, language, and motor skill that actually may declare the patient 
symptomatic, but go unreported.  Some of the possible symptoms that have not been well 
documented thus far relate to the frontal and temporal lobe functions in the brain that also 
receive blood supply from the major ICA branches.  These functions (physical, emotional and 
cognitive in nature) seem to escape being communicated in the clinical history and examination 
of the patient.58 Yet, when specifically addressed in the clinical examination, there often is 
acknowledgement of forgetfulness, decreased ability to communicate in a swift and accurate 
manner, thought disorganization, and an overall feeling of “just not being myself” by the patient 
(personal observation).  Specific testing of these functions would provide symptomatic 
information about the patient that might be overlooked or missed entirely in the neurologic 
examination.  Deficits identified in these areas may help the physician to decide further medical 
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management and diagnostic work-up to determine if the patient may actually have significant 
carotid artery disease and be in need of possible cerebral hemodynamic assessment. 
2.4.  Assessment Measures of Cognitive and Physical Function 
 
There has not been identified any specific cognitive or physical function assessment tools that 
are acceptable and standard to test this population of patients with symptomatic and 
asymptomatic carotid artery disease.  In most of the studies that investigated these patient groups 
to assess interventions and medical care, the outcome measures are primarily a transient ischemic 
attack, stroke or death.5,14,24,25,57 
 
In only a few studies reviewed thus far, has there been any specific assessment tools used to 
evaluate cognition and/or physical ability in patients with carotid artery stenosis or occlusion.  
Cognitive function has been addressed in a few studies examining atherosclerosis of the common 
carotid and internal carotid arteries.59-61  Auperin et. al considered middle-aged adults (45-71 
years old) and measured atherosclerosis of the common carotid artery alone.61  Cerhan et. al. 
considered middle-aged adults (45-71 years old) and averaged the measurement between the 
common carotid and internal carotid artery areas of atherosclerosis.59  Both studies identified an 
association between presence of atherosclerosis and cognitive decline.  Auperin et. al found this 
to be a moderate association more prevalent in men.61  Cerhan found that a greater carotid 
intima-media wall thickness (averaged measurement) was associated with lower cognitive 
scores, and this was not gender specific.  Breteler et. al. researched cardiovascular disease and 
cognitive function in the elderly (55-94 years old), and concluded that atherosclerotic disease of 
the peripheral or carotid arteries accounts for considerable cognitive impairment in these 
individuals.60  However, what was not clear in these studies is the amount of atherosclerosis, and 
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the symptomatic or asymptomatic status of the participants.  In one recent study of patients 65 
years and older with symptomatic carotid artery stenosis of 75% or greater, neuropsychological 
function was the main outcome measure considered.  The researchers concluded that despite the 
small sample size of the study, there was some evidence for an association between severe 
carotid artery stenosis and impaired neuropsychological function.62  The only study identified 
that has dealt with patients with asymptomatic carotid artery disease and cognitive impairment, 
demonstrated that cognitive impairment and decline are associated with severe carotid artery 
stenosis (> 75%) of the left internal carotid artery primarily.7  None of these studies included any 
assessment of physical function. 
 
Cognitive function has been more extensively studied in patients with cardiovascular related 
disorders, including those undergoing cardiac surgery.63-68  From a review of the literature it 
appears that even though there was a consensus statement  published in 1995 on the assessment 
of neurobehavioral outcomes after cardiac surgery, there continues to be deviation from the 
recommended core neuropsychological battery in this consensus statement.69  It has been 
demonstrated that patients who have cardiac disorders do demonstrate impaired 
neuropsychological function.  For example, Zuccala et.al. and Riegel et.al. found that older 
patients with heart failure show cognitive impairments at an incidence of 26% and 28.6% 
respectively.63,64  Zuccala et.al. determined that lower systolic blood pressure was selectively 
associated with cognitive impairment.63,64  Other cardiac conditions that have been found to be 
related to impaired cognition would include patients with atherosclerosis of the common carotid 
artery, patients with arrythmias, particularly atrial fibrillation, and patients that undergo coronary 
artery bypass surgery.65,67,70-72  Figure 6 is a summary of the studies reviewed in the 
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cardiovascular literature that assess cognitive function and the variety of outcome measures 
utilized. 
Investigators Neuropsychologic 
Tests Used 
Function Assessed 
Riegel et. al.64  • Commands subset 
and Material subset 
of Boston 
Diagnostic Aphasia 
Examination73  
 
• Complex Ideational 
Material subset of 
Boston Diagnostic 
Aphasia 
Examination73  
 
• Mini-Mental State 
Examination 
(MMSE)74  
 
 
 
 
 
 
 
 
• Draw A Clock 
Test73  
 
• Aural attention span, 
auditory 
comprehension, 
planning and 
execution and motor 
skills 
• Executive Brain 
Function 
 
 
 
 
• Orientation, 
attention, 
concentration, 
sequencing, 
visuospatial skills, 
verbal learning, 
immediate memory, 
oral reading and 
comprehension, 
verbal repetition 
 
• Attention and 
concentration, 
numerical 
sequencing, visual-
spatial analysis and 
execution, abstract 
conceptualization 
and planning 
Zuccala et.al.63  • Hodkinson 
Abbreviated Mental 
Test75  
• Cognitive screen 
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Rao62  • Cambridge 
Cognitive 
Examination 
(CAMCOG)76  
 
 
• Behavioral 
Dyscontrol Scale 
(BDCS)77  
• Trail-Making Tests 
A and B78  
• Controlled Word 
Association Test79  
• Abstract thinking, 
attention, 
calculation, 
memory, language, 
orientation, praxis, 
perception 
• Frontal lobe 
function 
 
• Frontal lobe 
function 
• Frontal lobe 
function 
Breteler et. al.60  • Mini-Mental State 
Examination 
(MMSE)74  
 
 
• Orientation, 
attention, 
concentration, 
sequencing, 
visuospatial skills, 
verbal learning, 
immediate memory, 
oral reading and 
comprehension, 
verbal repetition 
van Exel et. al.65  • Mini-Mental State 
Examination 
(MMSE)74  
 
• Orientation, 
attention, 
concentration, 
sequencing, 
visuospatial skills, 
verbal learning, 
immediate memory, 
oral reading and 
comprehension, 
verbal repetition 
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Auperin et. al.61  • Mini-Mental State 
Examination 
(MMSE)74  
 
 
 
 
 
 
 
• Trail-making B78 
Digit Symbol 
Substitution Test – 
Weschler Intelligence 
Scale – Revised80  
• Paced Auditory 
Serial Addition 
Test81  
• Benton Visual 
Retention Test79  
• Rey’s Auditory 
Verbal Learning 
Test82  
• Word Fluency Test79
• Raven Progressive 
Matrices83  
 
• Orientation, 
attention, 
concentration, 
sequencing, 
visuospatial skills, 
verbal learning, 
immediate memory, 
oral reading and 
comprehension, 
verbal repetition 
• Frontal lobe 
function 
 
 
 
• Psychomotor 
performance 
 
• Auditory attention 
 
• Visuospatial 
perception 
 
• Verbal memory  
• Frontal lobe 
function 
• Logical intelligence 
and reasoning 
Cerhan et. al59  • Delayed Word 
Recall Test84  
• Digit Symbol subset 
of the Weschler 
Adult Intelligence 
Scale – Revised80  
• Controlled Oral 
Word Association 
Test79  
 
 
• Verbal learning and 
recent memory 
• Psychomotor 
performance 
 
 
• Frontal lobe 
function 
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Mahanna et. al. 199667  • Randt Memory Test 
(short story)85  
• Digit Symbol subset 
of the Weschler 
Adult Intelligence 
Scale – Revised80  
• Trail-making B78 
 
• Benton Revised 
Visual Retention 
Test79 
• Short and long term 
memory 
• Psychomotor 
performance 
 
 
• Frontal lobe 
function 
• Visuospatial 
perception 
 
Vingerhoets et. al.71  • Auditory Verbal 
Learning Test86  
• Verbal memory 
performance 
Stroobant et. al.39 • Rey Auditory 
Verbal Learning 
test82 
• Trail-making B78 
 
• Grooved Peg-Board 
Test87 
• Block Taps test  
 
• Line Bisection 
Test88  
 
• Controlled Oral 
Word Association 
Test79  
• Judgement of Line 
Orientation79 
• Verbal Memory 
 
 
• Frontal lobe 
function 
• Complex motor 
coordination 
• Immediate memory 
and attention 
• Unilateral visual 
inattention 
 
• Frontal lobe 
function 
 
• Estimate angular 
relationships 
BhaskerRao et. al.89  • Antisaccadic Eye 
Movement Test 
(ASEM)90  
• Frontal lobe 
function 
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Pugsley et.al.91  • Letter Cancellation 
Test27  
• Trail Making Tests78 
• Computerized 
Symbol Digit 
Replacement Test92  
• Computerized 
Reaction Time 
task91  
• Purdue Pegboard 
Test93 
• Rey Auditory 
Verbal Learning 
test82 
• Computerized 
Nonverbal 
recognition Memory 
Tests91  
• Block Design subset 
of the Weschler 
Adult Intelligence 
Scale – Revised94  
• Frontal lobe 
function 
• Attention 
 
• Reaction time 
 
 
• Motor skills 
 
 
• Verbal Memory 
 
• Memory 
 
 
• Psychomotor 
Performance 
 
 
 
 
Taggart et. al.95  • Rey Auditory 
Verbal Learning 
test82 
• Digit Span subset of 
the Weschler Adult 
Intelligence Scale – 
Revised80  
• Trail Making Tests78 
 
• Nine Hole Peg-
Board Test87 
• Bells Test54  
• Adult Memory 
Information 
Battery94  
• Short Orientation 
Memory 
Concentration Test96 
• Verbal Memory 
 
 
• Psychomotor 
Performance 
 
 
• Frontal lobe 
function 
• Psychomotor speed 
 
• Visual search 
• Speed of 
information 
processing 
• General cognitive 
orientation 
Figure 6:  Summary of Neuropsychological Tests in Cardiovascular Disorders. 
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There has been some attention to subtle cognitive changes in patients undergoing carotid 
endarterectomy (CEA) with preoperative and postoperative assessments and follow-up.58, 97-99  In 
these studies, a variety of neuropsychometric tests were used. The reasoning offered for 
preforming a  neuropsychological assessment stemmed from the Statement of Consensus on 
Assessment of Neurobehavioral Outcomes after Cardiac Surgery, which advocated the 
assessment of central nervous system outcomes after cardiac surgery, specifically 
neurobehavioral outcomes.69,99  The specific core neuropsychologic battery recommended in the 
Consensus Statement69 includes the Rey verbal learning test, the Trail-making A test, Trail-
making B test, and the Grooved pegboard test.78,82,87 
 
Once again, in the studies investigating neurobehavioral outcomes after carotid endarterectomy, 
the wide variety of tests used are reflective of cognitive function in 3 main areas: fine motor 
control, executive function and verbal memory.99  The chart below is a summary of the studies 
reviewed and neuropsychological tests used.58,97-100 (Figure 7). 
Investigators Neuropsychologic 
Tests Used 
Function Assessed 
• Owens, Pressman, 
Edwards et.al.97  
• Ravens standard 
progressive 
matrices83 
• Finger tapping101  
 
• Spatial orientation102 
 
• Arithmetic103 
 
• Vocabulary104 
• Short-term 
memory94  
• Short interval time 
perception105 
• General intelligence 
 
 
• Motor performance 
 
• Comprehend visual 
space 
• Spatial/ verbal 
abilities 
• Verbal function 
• Short-term memory 
 
• General test of 
cerebral function 
Cushman, Brinkman, Ganji • Weschler Adult • Intelligence 
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et.al.98  Intelligence Scale80 
• Russell’s Revised 
Weschler Memory 
Scale80  
• Buschke’s Selective 
Reminding 
Procedure106  
• Trail Making Test78 
 
 
• Digit Symbol 
Substitution Test101 
 
• Reitan Finger 
Tapping Test101 
• Reitan Sensory-
Perceptual 
Examination101 
 
• Complex Memory 
 
 
• Memory retention 
and retrieval 
 
• Visual conceptual 
and visuo-motor 
tracking 
• Spatial/ verbal 
abilities 
 
• Motor Performance 
 
• Sensory-perceptual 
processing 
Heyer, Adams, Solomon 
et.al.99  
• Halsted-Reitan 
Trails A & B78 
 
• Fine finger 
tapping101 
• Grooved pegboard 
test87 
• Buschke Selective 
Reminding test106 
• Visual conceptual 
and visuo-motor 
tracking 
• Manual dexterity 
 
• Complex motor 
coordination 
• Verbal memory 
Connolly, Winfree, 
Rampersad et.al.58 
• Halsted-Reitan 
Trails A & B78 
 
• Controlled oral word 
association79 
• Rey complex finger 
test (copy portion)82 
• Visual conceptual 
and visuo-motor 
tracking 
• Verbal fluency 
 
• Perceptual, 
visual/spatial 
organization 
Fearn, Hutchinson, Riding 
et.al.100  
• Cognitive Drug 
Research Ltd. 
(Reading, UK)107  
• Overall memory 
reaction time for 
word, picture and 
memory scanning,  
• Overall attention 
reaction time  
• Memory 
 
 
• Attention 
 
 
 
 
Figure 7:  Summary of Neuropsychological Tests in Carotid Endarterectomy.
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The possibility of impaired cognition appears to be significant as shown in a recent study by 
Connolly et.al. of  55 patients who underwent CEA.  In this study, 20-25% of the patients were 
found to have subtle cognitive injuries postoperatively.58 
 
In an additional review of related literature pertaining to patients at risk for stroke due to 
ruptured aneurysms resulting in the development of a subarachnoid hemorrhage, some other 
cognitive and physical assessment tools were used.  Once again there is no suggested assessment 
tool for impaired cognition.  The only outcome scale that consistently appeared in that literature 
was the Glasgow Outcome Scale.108,109  This scale reflects recovery in general with no specific 
attention to cognitive or physical deficits.  Others scales more specific to cognition that have 
been used for the ruptured aneurysm population of patients with subarachnoid hemorrhage 
include:  the Weschler Intelligence Test110 and Weschler Memory Scale,94 short-term memory 
tests and sensori-motor coordination tests, digit span tests and recognition memory 
tests111.108,109,112  Once again, it is clear that there is no specifically identified and recommended 
mechanism for testing cognitive and physical function in patients with related neurological 
disorders. 
2.4.1.  Relationship of Cognitive Function and Instrumental Activities of Daily Living 
 
Instrumental activities of daily living (IADL) include items that consider competence beyond the 
basic activities of daily living (grooming, toileting, feeding).113  Examples of IADL’s include 
light household tasks, shopping and money management, meal preparation, transportation, and 
responsibility for medications.113  These activities render a person more functionally independent 
in their environment and social interactions beyond the limits of their home.  Grigsby et.al. 
demonstrated a relationship between executive cognitive abilities and functional status through 
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assessing ADL’s and IADL’s, and determined that executive function is an important 
determinant of functional status.114  A similar finding was found by Pohjasvaara et. al. who 
tested 486 patients who were 3-4 months post ischemic stroke.  The researchers found that a 
clinically significant decline in executive function was frequent in this group (40.6%), and that 
this significantly correlated (p<.0001) with a poorer performance in complex activities of daily 
living.115  These researchers recommended that measures of executive functions including 
complex ADL’s may be a more sensitive measure for early vascular impairment than an 
assessment of basic activities of daily living.115  It has been shown in the literature that if a 
person is experiencing a disruption of cognition, then there is a related decline in IADL 
function.116-118 
2.4.2.  Assessment Tools for this Project 
The assessment tools chosen for this project have been selected in order to focus on six cognitive 
domains and physical function, including instrumental activities of daily living.  The cognitive 
tests chosen were the Repeatable Battery for the Assessment of Neuropsychological Status 
(RBANS) and the Executive Interview (EXIT).119-121 (Appendix A,B)  The Physical Performance 
Test (PPT) was used as the physical function measure.122 (Appendix C)  The Instrumental 
Activities of Daily Living Scale (IADL) was used to assess complex activities of daily living.113 
(Appendix D)  
2.4.2.1.  The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) 
The RBANS was developed to identify and characterize cognitive decline in the older adult, as 
well as serve as a neuropsychological screening battery for younger patients.119  It tests 5 
domains of cognitive function that include:  
• Immediate (short-term) memory –list learning, story memory tests 
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• Delayed (long-term) memory – list recall, list recognition, story recall, figure recall tests  
• Visuospatial/constructional function – figure copy, line orientation tests  
• Language – picture naming and semantic fluency tests 
• Attention - digit span and coding tests 
The RBANS is a recently developed test battery that has been recognized as a clinically useful 
tool to rapidly screen neuropsychological status in the acute care setting for the purpose of 
medical and surgical decision making as opposed to using a lengthier test battery.121  The length 
of the test is approximately 30 minutes.119   At its creation, standard normal measurements were 
developed for each age group for each subtest of the RBANS.121  Reliability was then calculated 
for each subtest in each age group and was reported to be greater than .8 for all age groups, with 
an overall total score reliability of .94.121  The RBANS is also reported as a valid test in a mixed 
adult population with a variety of neuropsychologic and psychiatric problems.121  Comparisons 
have been made to some select, well-established external measures such as the Weschler 
Memory Scale-Revised (WMS-R).94  In this comparison, the RBANS total scale score was 
moderately correlated with the WMS-R verbal memory index at .7.121  The test has been shown 
in the literature to have preliminary clinical validity in detecting and characterizing dementia.119  
It was also found to have sensitivity and specificity in people with dementia at 90%.119  Many of 
the patients with symptomatic carotid artery disease complain of a loss of memory, forgetfulness, 
or trouble finding the right words during communications.  Also, once asked, some patients that 
are asymptomatic or their family members recognize these types of difficulties in purported 
asymptomatic patients.  The domains tested in the RBANS are functions similar to those 
reported by both patients and their families, thus this test was chosen for this project. 
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2.4.2.2.  Executive Function 
The sixth cognitive domain, executive cognitive function is assessed via the EXIT.120  Executive 
cognitive function is the process of orchestrating relatively simple actions such as movements 
and ideas, into goal-directed behaviors.  This function is associated with the frontal lobe; an area 
already identified at risk for decreased blood flow after carotid artery occlusion.123  The EXIT is 
designed to be administered efficiently (10 minutes), conveniently (even at a patient’s bedside) 
and by non-psychiatric personnel.120 The internal consistency of the 25-item tool was found to be 
high (Cronbach’s alpha = .87).120  In the pilot validation study, it was shown to be a valid and 
reliable tool to assess executive impairment at the bedside, and discriminated between different 
functional levels of persons tested and severity of their dementia.120  Additionally, the EXIT 
correlated strongly with the Mini-Mental State Examination (MMSE), however, was better able 
to discriminate between the functional levels of the patients studied.120   
2.4.2.3.  Assessment of Physical Performance 
The Physical Performance Test can be either a 7-item or 9-item global measure of physical 
performance with items that reflect both basic activities of daily living (BADL) and instrumental 
activities of daily living (IADL).122  The items include: 
• Writing a sentence 
• Simulated eating 
• Donning and doffing a jacket 
• Turning 360º while standing 
• Lifting a book 
• Picking up a penny from the floor 
• Walking 50 feet 
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• Climbing one flight of stairs 
• Climbing several flights of stairs (up to 4) 
The measure was developed to assess the physical performance of older adults, however is useful 
in the population that is at risk for stroke due to carotid artery stenosis and occlusion, to 
determine if any of the possible physical and sensory symptoms are affecting their function.  
Recently, Brach et.al. used the 7-item PPT to identify deficits in a high-functioning sample of 
community-dwelling older women.124  The tool was more useful in identifying deficits in 
physical function than the self-report comparison measure, the Functional Status 
Questionnaire.124  The authors concluded that the performance-based measure (the PPT) could 
assist in early identification of minor problems in physical functioning, and allow for opportunity 
for early intervention for the patients.124  The use of the PPT in this project is similar, to identify 
early the minor deficits in physical function that the patient may not otherwise report. 
 
The PPT 9-item scale has been shown to demonstrate internal consistency (Cronbach’s 
alpha=.87), and interrater reliability (r =.99).122  The PPT has been found to demonstrate 
concurrent validity with other functional status assessments, namely the modified Rosow-
Breslau,125and the Katz Activities of Daily Living126 and the Spector scale127 with a Pearson 
Correlation Coefficient of r=.50-.69.128  In this study, the PPT was also found to demonstrate 
predictive validity for the outcomes of death and institutionalization in the elderly subjects 
tested.  Reuben et.al. concluded that this tool, due to its assessment of actual performance, would 
be a useful tool in a research situation.128  While the reliability and validity of this tool has not 
been tested in the population of patients with symptomatic or asymptomatic carotid artery 
disease, it appears to be a valuable test to use to reflect a patient’s ability to complete important 
  36 
ADL’s.  Also, the test takes approximately 10 minutes to administer, and uses very little 
equipment, thus it is a convenient and practical tool to use in this project. 
2.4.2.4.  Instrumental Activities of Daily Living 
The Lawton assessment of instrumental activities of daily living was developed to assess 
everyday functional competence.113  The tool consists of nine items that reflect more complex 
daily activities including:  telephoning, shopping, food preparation, laundering, housekeeping, 
obtaining transportation, money management, use of medication, and handyman work.  Persons 
self-report on the assessment if they are able to complete a task without help, with some help, or 
are completely unable to complete the task.  The maximum score on the test is 27, which 
indicates complete independence with the tasks on the tool.  The tool takes approximately 5-7 
minutes to administer.  At the time of the development of the tool, the Lawton IADL was found 
to be a valid measure, correlating moderately with similar scales.113  It was also found to be a 
practical scale for use in a variety of elderly age groups.113  In the initial publication of the tool, 
its reliability had not yet been extensively tested.  However, the scale continues to be used 
frequently in the literature to reflect IADL function,115,116,129,130 and has been recommended for 
the assessment of persons who have had a stroke as part of the Comprehensive Assessment 
Toolbox for Stroke.131  Thus it is an appropriate measure for this project, which is focused on 
identifying a persons loss of function as a potential contribution to increase stroke prevention. 
2.5.  Summary: 
 
Currently, there is no agreement in the literature regarding the management of patients with 
internal carotid artery stenosis and occlusion.  There is more information regarding stroke risk 
and possible interventions to address prevention in cases of carotid stenosis and symptomatic 
carotid occlusion than in asymptomatic patients.13  There also exists a better description of 
symptomatic patients from both a clinical perspective and a physiologic perspective.  However, 
  37 
information regarding some cerebral functions and physical measures are missing from the 
clinical data currently being assessed and evaluated.  There is no standardized protocol for the 
inclusion or evaluation of cognitive and physical functions.  These clinical data may provide 
insight into the actual functional deficits of the patient, and the existence of symptoms that may 
be interpreted as warning signs of impaired cerebral function and possible stroke.  Thus, the 
question remains as to the accurate clinical picture of the patient, both those with symptoms and 
those who are believed to be asymptomatic. 
2.5.1.  Specific Aim 
The first specific aim of this research project is to determine if persons with asymptomatic 
carotid artery disease (high moderate stenosis through occlusion) demonstrate deficits in 
cognition and on physical performance measures. 
 
The second specific aim is to determine if there is a correlation between the cognitive measures 
and the instrumental activities of daily living in persons with asymptomatic carotid artery 
disease. 
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III.  Research Hypothesis: 
 
Hypothesis 1: 
Ho:  Patients with asymptomatic carotid artery disease (moderate, severely stenotic or occluded) 
will demonstrate a deficit on the RBANS and EXIT measures of cognitive functioning and on 
the Physical Performance Test.  
Hypothesis 2: 
Ho:  There will be a negative correlation between the persons with asymptomatic carotid artery 
diseases cognitive scores on the RBANS and EXIT and their scores on the Lawton Instrumental 
Activities of Daily Living Scale. 
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IV.  Research Design and Methods 
This was a prospective, observational, research study conducted at the Stroke Institute and 
Neurosurgery clinic at University of Pittsburgh Medical Center.  Patients with a diagnosis of 
asymptomatic carotid artery stenosis of high moderate and severe degrees, and occlusion were 
included. Degree of stenosis and occlusion of the carotid artery was identified by the physician 
via angiography, CT, CTA, or MRI/MRA.  All patients were 50 years of age or older.  Patients 
were able to answer questions concerning memory and thinking skills, and participate in a 
physical assessment reflecting activities of daily living.   Patient testing time took between 40 
and 50 minutes. 
 
Patients were identified by the neurologists of the University of Pittsburgh Stroke Institute and 
the neurosurgeon and nurse coordinator of the cerebrovascular center.  The physician first 
consented the patient to participate in a research study, then the primary investigator spoke to the 
patient and explained the research study after the patient had consented.  Data was typically 
collected at that time, unless it was inconvenient for the patient.  Data collection required only 
one visit of the patient.  
4.1.  Inclusion/Exclusion Criteria for Patients. 
The 39 patients included had a diagnosis of asymptomatic carotid artery stenosis of 50% or 
greater, through complete carotid artery occlusion and were placed in one of the following 
categories28,49: 
• Unilateral moderate stenosis (50-69%) 
• Unilateral severe stenosis (70-99%) 
• Unilateral occlusion 
• Bilateral moderate stenosis (50-69%) 
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• Bilateral severe stenosis (70-99%) 
• Bilateral occlusion 
Asymptomatic patients are by patient report, symptom free.  
 
Patients were excluded from the study if they had experienced a previous stroke. They were also 
excluded if they were unable to understand the questions or to verbally respond in person.  
Persons with a preexisting dementia, as diagnosed by the physician, were excluded.  Also, 
preexisting orthopedic conditions that could preclude the patient from completing the physical 
testing were excluded, such as being non-weight bearing or severe cardiopulmonary 
compromise. 
4.2.  Research Design: 
4.2.1.  Patients with Carotid Artery Disease: 
Once a patient was identified as a candidate for the study and agreed to participate, he/she was 
approached by the primary investigator to give informed consent to participate.  Once consented, 
each patient was tested one time on the cognitive and physical measures.  These measures were:  
the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS) and the 
Executive Interview (EXIT), the Physical Performance Test (PPT), and the Instrumental 
Activities of Daily Living Scale (IADL).  Prior to administration of the tests, the patient’s 
demographic data (age, comorbidities, level of education), a list of medications, documentation 
of the absence of symptoms, documentation of the diagnostic tests used to make the diagnosis of 
stenosis and occlusion, which side or sides were involved, and if there is blood flow 
documentation from cerebral hemodynamic testing were obtained.  Testing of the patient took 
place in the clinic, and took approximately 40-50 minutes, 30 minutes for the cognitive measures 
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(RBANS-25 minutes, EXIT-10 minutes), and 10-15 minutes for the Physical Performance Test 
and Lawton IADL score. The order of testing was randomly varied between patients, with the 
patient blindly selecting the 1st, 2nd  3rd, and 4th test via a drawing.  There was a 2-3 minute rest 
between each test (RBANS, EXIT, PPT and IADL).  No patient approached to participate in the 
study refused. 
 
All testing was done by the primary investigator.  The primary investigator had practiced each of 
the tests prior to the collection of the pilot data.  The RBANS and EXIT were tested with a PhD 
Neuropsychologist through Western Psychiatric Hospital.  The PPT was co-administered with a 
co-author (S.W.) who has tested a few hundred patients, and has published articles regarding the 
use of the test.  The primary investigator has performed reliability testing on the PPT with S.W. 
with a strong correlation r = .92 .   
4.3.  Data Analysis: 
The predicted sample size for this project was 26 patients in each group: unilateral high moderate 
stenosis (50-69%), unilateral severe stenosis (70-99%), unilateral occlusion, bilateral high 
moderate stenosis, bilateral severe stenosis and bilateral occlusion (156 patients total).  In the 
case of bilateral disease, the patients were assigned to the group of the most involved artery.  The 
sample size for patients was based on an alpha = .05 and power = 80% with a moderate effect 
size.   
 
It was a challenge to identify the patients who were asymptomatic, as asymptomatic carotid 
artery disease is often an incidental finding to another problem for the patient.  It was estimated 
that 6-8 patients in this category could be identified per month.  It would take 1-2 years to 
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identify and test the predicted number of subjects.  Therefore, patients were identified and tested 
for 8 months after data collection began. 
 
Descriptive data calculated for asymptomatic patients with carotid artery disease included a 
mean and standard deviation for each measure in each group. RBANS data for the asymptomatic 
patients were compared to the established norms for the tools used.132  A one-sample t-test with 
one tail was used to compare the data to the assessment tools’ established normal values, based 
on the patient’s age.  The rationale for use of a one-tail test was because it was not expected that 
patients would perform better than the established normal scores.  A higher EXIT score would 
indicate greater executive dyscontrol.  The mean score for each patient group (unilateral and 
bilateral high moderate, severe stenosis and occlusion) was used to characterize the group.  This 
was compared to other similar populations that are described in the literature.  The mean PPT 
score was compared to the perfect score (36), to identify decline in function.  Additionally, a 
Pearson Correlation Coefficient was calculated comparing all the patients’ cognitive scores 
(RBANS and EXIT) with the Lawton IADL scores. 
 
The established standardized sample scores, by age group for each test in the RBANS was found 
in Appendix A of the Stimulus Booklet.132  These values are standardized to a normal 
distribution, thus a mean score of 100 and a standard deviation of 15 was used in the statistical 
analysis.121 
 
The EXIT is a 25-item test with a maximum possible score of 50.  A higher score would indicate 
a greater amount of executive dyscontrol.120  In the literature, there is a suggested cut-off score of 
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15/50 or greater for this test to denote a person as having executive dyscontrol.120  There have 
been studies that have used the EXIT to investigate impaired executive function between 
institutionalized and non-institutionalized patients, between retirees that need different levels of 
care, and also between different types of dementias.120,123,133  In two of these studies, there were 
samples of subjects who were living without assistance and non-institutionalized, for whom the 
EXIT score was expected to be relatively low, indicating that executive function was not 
impaired in those subjects.120,123  In the pilot validation study, the average non-institutionalized 
subject age was 85.6 years, and the average EXIT score was 14.2/50.120  In the later study that 
used the EXIT to assess executive dyscontrol and level of care, the average age of the 
community dwelling subjects was 74.6 years, and the average EXIT score was 9.4/50.123  For 
this project, the expected average age of the patients was predicted to be less than those of the 
two studies discussed.  It was expected that most of the patients would be between 50 – 70 years 
old.  A score of 15/50 or greater, as has been suggested in the literature was used as the normal 
comparison by the primary investigator.  This choice was based on the results of the previously 
described studies. 
 
The Physical Performance Test is a test that was developed for elderly outpatients.  The test was 
appropriate for this project due to the incorporation of activities of daily living which are an 
important physical measure, and the benefit of its being a direct observation test. While not all 
patients with carotid artery disease are elderly, the ages of the patients in the project were not 
anticipated to vary greatly from age 65.  The average age in the study was 73 years old.  The PPT 
was tested in 5 patient populations with ages greater than 65.122  The score on the 9-item test 
ranges from 0-36, with 36 indicating the highest function. The mean score found in this study for 
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the 9-item test was 27, with the 90th percentile score being 31 and the 75th percentile score being 
29.122  Sherman and Reuben used the 7-item PPT to assess the functional status of 363 
community-dwelling elders and demonstrated that the test had no floor or ceiling effect.134  The 
choice of the 7-item test eliminated the two activities that included stairs.  In another validation 
study by Reuben et.al., the 7-item and 9-item PPT were evaluated in an elderly cohort.  The 9-
item average test score reported for 124 subjects with an average age of 79.8 years was 24.6, and 
this score was the same for the subjects of this group who were considered community 
dwelling.128  Recently, in a study by Brach et. al. the 7-item PPT was used to assess a decline in 
function in community-dwelling older women (mean age = 74.3 years).124  In this study, the 
researchers chose a perfect score of 28 (4 points in each category) as the expected score for 
normal performance.  Any score below this indicated a deficit in physical performance of that 
particular task.124  In contrast, unpublished data of 19 normal healthy subjects in the age range of 
50-70 years (mean age 67.5) demonstrated a mean score on the 9-item PPT of 30/36.135  This 
suggests that the concept of a perfect score 36 (4 points per task) might need to be reconsidered 
as a realistic expectation for the healthy normal population. 
 
For this project, the 9-item test was selected, as negotiating stairs is an important part of function 
in some homes, and in the community.  However, a 7-item score was also analyzed, to allow for 
individual item analysis.  The PPT score was recorded from the 0-4 scale in the tool, and also 
time of completion for 7 of the 9 tasks was recorded.  A score of 36 could be suggested as the 
“normal”comparison, considering the rationale offered by Brach et. al, that scores less than 4 on 
each item mean that the task requires more time to complete  than the best performance, and this 
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is an indicator of early physical decline.124  Similarly, this project was designed to detect early 
decline, particularly in the persons with asymptomatic carotid artery disease. 
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V.  Results 
 
5.1.  Demographic Data 
 
Thirty-nine patients with asymptomatic carotid artery disease were tested.  Table 1 includes the 
basic demographics regarding these patients.  The sample was slightly dominant for males, with 
an average age of 73 years (48-87). 
Table 1:  Patient demographics by diagnostic group: 
Diagnostic Group Gender Mean Age (yrs.) ± 
Standard Deviation 
Age Range 
Unilateral Stenosis 
Moderate 
n = 3, (7.7%) 
2 male    (67%) 
1 female (33%) 
78  ± 6.23 71-83 
Unilateral Stenosis  
Severe 
n = 18, (46.2%) 
11 male  (61%) 
7 female (39%) 
75  ± 7.65 55-87 
Unilateral Occlusion 
n = 3, (7.7%) 
2 male    (67%) 
1 female (33%) 
63  ± 15.5 48-79 
Bilateral Stenosis 
Moderate 
n = 4, (10.3%) 
3 male    (75%) 
1 female (25%) 
76  ± 8.14 66-85 
Bilateral Stenosis 
Severe 
n = 9, (23.1%) 
5 male    (56 %) 
4 female (44%) 
73  ± 5.48 64-79 
Bilateral Occlusion 
n = 2, (5.1%) 
1 male    (50%) 
1 female (50%) 
63 ± 4.95 59-66 
All Patients  
(n = 39) 
23 male    (59%) 
16 female (41%) 
73 ± 8.49   48-87 years 
 
Most patients (70%) tested in this study were severely stenotic, with another 13 % being 
occluded, and the remaining 17% had moderate carotid artery stenosis.   
 
Table 2 reflects which side was involved for the patients.  Patients with bilateral involvement 
were grouped into the side of stenosis that the surgeon would be considering for surgery.  For 
example, in a situation of mild or moderate stenosis on the left side, and severe stenosis on the 
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right side, the patient was classified as having a right side that was involved.  In situations when 
the level of stenosis was the same, or occlusion existed bilaterally, then the patient was classified 
with bilateral disease. 
Table 2:  Patient Demographics by involved side of stenosis: 
Patient 
Group 
Right 
side 
Gender Age 
(Mean)
Left 
side 
Gender Age 
(Mean) 
Both 
sides 
Gender Age 
(Mean) 
Unilateral 
Stenosis 
Moderate 
(n = 3) 
2 1 male 
1 female 
82 1 1 male 84    
Unilateral 
Stenosis  
Severe  
(n = 18) 
10 6 male 
4 female 
77 
73 
8      
Unilateral 
Occlusion 
(n = 3) 
2 2 male 64 1 1 female 62    
Bilateral 
Stenosis 
Moderate 
(n = 4) 
   2 2 male 76 2 2 female 76 
Bilateral 
Stenosis 
Severe 
(n = 9) 
   1 1 male 69 8 4 male 
4 female 
72 
74 
Bilateral 
Occlusion 
(n = 2) 
      2 1 male 
1 female 
63 
 
In general for the 39 patients, there were 13 with right side involvement, 14 with left side 
involvement and 12 with bilateral involvement. 
 
Other data collected to further describe the patients was the number of comorbidities that each 
person had, and the types of medications that the patients were taking.  Table 3 is a summary of 
the most common comorbidities that the patients displayed. 
  48 
Table 3:  Comorbidities in Patients with Asymptomatic Carotid Artery Disease: 
Comorbidity Number of Patients (% of the total 39) 
Hypertension 15 (38.5%) 
Diabetes Mellitus 13 (33.3%) 
Coronary Artery Disease 12 (30.8%) 
Cardiac Arrythmia 5 (12.8%) 
Hypercholesteremia 14 (36%) 
Other (various diseases not related to 
carotid artery disease) 
49 
 
Some examples of comorbidities in the other category would include glaucoma, non-disabling 
cancers (i.e. prostate cancer, breast cancer), arthritis, diverticulitis, and renal insufficiency.  None 
of the comorbidities were present in a majority (over 50%) of the patients.  Hypertension, 
diabetes, coronary artery disease and hypercholesteremia all were present in approximately one-
third of the patients. 
Table 4 is a summary of the medications that the patients were taking, divided into categories.136 
Table 4:  Medications in Patients with Asymptomatic Carotid Artery Disease. 
 
Medication Classification Medication Number of Patients taking 
the medication 
Anticoagulant Plavix 
Coumadin 
6 
6 
Total:  12 
CNS Agent (Analgesic, 
Anticonvulsant, Antidepressive, 
Selective serotonin reuptake 
inhibitor, Sedative) 
Aspirin 
Dilantin 
Effexor 
Celexa 
Zoloft 
Wellbutin 
Darvocet 
Celebrex 
Vioox 
21 
1 
1 
2 
2 
1 
1 
2 
1 
Total:  32 
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Antilipemics Zocor 
Lipitor 
Lopid/Gemfibrozil 
Tricor 
10 
7 
1 
1 
Total:  19 
Antihypertensive Lopressor 
Prinivil 
Diovan 
Atenol 
Corgard 
Hytrin 
Perindopril 
Zestril 
Cozaar 
Vasotec 
Diltiazem 
Capoten/Captopril 
3 
5 
3 
7 
1 
1 
1 
1 
1 
2 
1 
1 
Total:  27 
Antiplatelet Aggrenox 2 
Total:  2 
Hormone and Synthetic Substrate Flourinef Acetate 
Synthroid 
Metformin 
Glucosome 
Glucotrol 
Proscar 
Insulin 
Glyburide 
Glucovance 
Actos 
1 
5 
4 
1 
1 
1 
3 
2 
1 
1 
Total: 21 
Bronchodialator Singular 1 
Total: 1 
Gastrointestinal Agent Zantac 
Prilosac 
Ranitidine 
2 
3 
1 
Total: 6 
ANS Agent Detrol 2 
Total: 2 
Cardiovascular Agent (Calcium 
channel blocker, antiarrythmic, 
ACE inhibitor) 
Norvasc 
Verapimil 
Accupril 
Lanoxin 
Digoxin 
Altace/ Ramipril 
2 
2 
1 
2 
1 
1 
Total: 9 
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Antigout Agent Allopurinol 1 
Total: 1 
Diuretic Hydrochlorothyazide 
Lasix 
3 
3 
Total: 6 
Antiglaucoma Isosorbide 1 
Total: 1 
Antivertigo Agent Meclizine/Antivert 1 
Total: 1 
Anti-infective/Antiviral Acyclovir 1 
Total: 1 
 
The medication categories most common in this patient group were the CNS agents (which 
included 5 different medications), the antihypertensives and the antilipemics.  Fifty-four percent 
of the patients were taking aspirin, and 26% were taking the anitlipemic Zocor.  They were the 
two most common medications.  In this study, outcomes were analyzed from two perspectives, 
the severity of carotid artery disease, and also from the perspective of differences in outcomes 
based on laterality of disease. 
5.2.  Analysis by Severity of Carotid Disease 
 
In order to determine differences in outcomes between the severity groups of the patients, an 
analysis of variance (ANOVA) was completed (Table 5).  
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Table 5:  ANOVA for between group differences based on severity of carotid disease on the 
RBANS, EXIT, PPT and the Lawton IADL. 
 
 Sum of 
Squares 
df Mean 
Square 
F Sig
. 
RBANS immediate memory 
  Between Groups 
  Within Groups 
  Total 
701.520
13889.147
14590.667
2
36
38
 
350.760 
385.810 
 
.909 .41
RBANS visualspatial/constructional 
  Between Groups 
  Within Groups 
  Total 
722.601
8358.322
9080.923
2
36
38
 
361.301 
232.176 
 
1.556 .23
RBANS language 
  Between Groups 
  Within Groups 
  Total 
264.562
6960.874
7225.436
2
36
38
 
132.281 
193.358 
 
.684 .51
RBANS attention 
  Between Groups 
  Within Groups 
  Total 
811.112
10130.324
10941.436
2
36
38
 
405.556 
281.398 
 
1.441 .25
RBANS delayed memory 
  Between Groups 
  Within Groups 
  Total 
27.643
11155.947
11183.590
2
36
38
 
13.821 
309.887 
 
.045 .96
RBANS total scale 
  Between Groups 
  Within Groups 
  Total 
479.319
10373.655
10852.974
2
36
38
 
239.660 
288.157 
 
.832 .44
EXIT Score 
  Between Groups 
  Within Groups 
  Total 
82.886
950.857
1033.744
2
36
38
 
41.443 
26.413 
 
1.569 .22
Physical Performance Test (nine-item total) 
  Between Groups 
  Within Groups 
  Total 
96.812
604.265
701.077
2
36
38
 
48.406 
16.785 
 
 
2.884 .07
Lawton IADL 
  Between Groups 
  Within Groups 
  Total 
 
5.082
62.353
67.436
2
36
38
 
2.541 
1.732 
 
1.467 .24
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With the 39 patients, there was not a significance difference between the groups (unilateral or 
bilateral moderate, severe disease, or occlusion) on any of the outcome measures.  The Physical 
Performance Test, however, was approaching significance (p<.07).  In a Tukey post-hoc analysis 
of the 9-item PPT, the moderate stenotic and severe stenotic groups were significantly different 
at a p<.10 level.  Because no significant differences between the groups were found at the p<.05 
level, the asymptomatic patients with unilateral and bilateral moderate, unilateral and bilateral 
severe, or unilateral and bilateral occluded carotid artery disease will be considered together for 
the remainder of the data analysis. 
5.2.1.  Cognitive Test Results by Level of Severity 
The results of the cognitive testing using the RBANS is reflected in Table 6.   
Table 6:  RBANS results for patients with moderate, severe carotid artery stenosis, or occlusion. 
 
SEVERITY Mean ± S.D. Std. Error 
Mean 
Occluded   RBANS immediate memory 
(n = 5)    RBANS visualspatial/constructional 
    RBANS language 
    RBANS attention 
    RBANS delayed memory 
    RBANS total scale 
 
97.6 ± 16
77.4 ± 11
94.2 ± 9
87.2 ± 15
86 ± 11
85.6 ± 11
6.97567 
4.79166 
4.02989 
6.88767 
4.84768 
4.69681 
Mod Stenosis   RBANS immediate memory 
(n = 7)    RBANSvisualspatial/constructional 
    RBANS language 
    RBANS attention 
    RBANS delayed memory 
    RBANS total scale 
 
83.7 ± 19
66.6 ± 9
90 ± 15
78.9 ± 12
87.3 ± 19
75.6 ± 13
7.05325 
3.51769 
5.53345 
4.67734 
7.07011 
5.07025 
Severe Stenosis RBANS immediate memory 
(n = 27)   RBANSvisualspatial/constructional 
    RBANS language 
    RBANS attention 
    RBANS delayed memory 
    RBANS total scale 
 
85.4 ± 20
77.9 ± 17
96.8 ± 14
90.9 ± 18
88.4 ± 18
84.4 ± 18
3.92714 
3.24222 
2.76065 
3.43077 
3.49736 
3.55116 
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A one-sample, one-tailed t-test was used to determine if these results were significantly different 
from the established normal score (100) on the test.  A one-tailed test was used as we were 
particularly interested in looking for a cognitive decline in the patients.  All 3 subgroups 
demonstrate a minimum of 3 cognitive areas of significant deficit as compared to the normal 
scores (Table 7). 
Table 7:  One-tailed t-test for cognitive function based on severity of disease. 
 
Severity 
 
RBANS DOMAIN t –value Significance  
(1-tailed, p<.05) 
Occluded Immediate Memory -.344 .37 
Visuospatial/constructional -4.717 .00* 
Language -1.439 .11 
Attention -1.858 .07 
Delayed memory -2.888 .03* 
n = 5 
Total Scale -3.066 .02* 
Moderate Stenosis Immediate Memory -2.309 .03* 
Visuospatial/constructional -9.503 .00* 
Language -1.807 .06 
Attention -4.520 .00* 
Delayed memory -1.798 .06 
n = 7 
Total Scale -4.818 .00* 
Severe Stenosis Immediate Memory -3.716 .00* 
Visuospatial/constructional -6.831 .00* 
Language -1.154 .13 
Attention -2.656 .01* 
Delayed memory -3.315 .00* 
n = 27 
Total Scale -4.370 .00* 
*p<.05 
In the occluded group, significant cognitive deficits were found in the visuospatial/ 
constructional (p<.00) and delayed memory domains (p<.03).  In the moderately stenotic 
subgroup, there was significant cognitive decline in the immediate memory (p<.03), 
visuospatial/constructional (p<.00), and attention (p<.00) domains. In the severely stenotic 
subgroup, there was significant cognitive deficit in all domains; immediate memory, 
visuospatial/constructional, delayed memory and total scale score (p<.00) and attention (p<.01) 
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except language.  All subgroups showed a significant cognitive decline on the RBANS Total 
Scale score, p<.02 in the occluded group, and p<.00 for the moderate and severe stenosis groups. 
 
Another area of cognition considered in this study was executive function.  Table 8 shows the 
mean score on the EXIT for each of the subgroups.   
Table 8:  Executive dysfunction (EXIT) results in patients with moderate, severe carotid artery 
stenosis or occlusion. 
 
 Number of patients Mean score ± S.D. 
Occluded 5 10 ± 5  
Moderate Stenosis 7 12.9 ± 6 
Severe Stenosis 27 9 ± 5 
Total 39 9.8 ± 5 
 
In considering a score of 15 or greater as indicating executive dysfunction, then the moderately 
stenotic subgroup is beginning to show a score closest to this.  However, the scores are all below 
15, and there is not a significant finding in these 39 patients.  
5.2.2.  Physical Performance Test Results by Level of Severity 
In the area of physical performance, as tested via the PPT (9-item), it was found that no patient 
reached a perfect score of 36/36.  For all 39 patients, scores ranged from 19/36 – 30/36 with a 
mean score of 27/36.  Table 9 is a summary of the PPT scores for the three different subgroups.   
Table 9:  Physical Performance Test (9-item) in patients with carotid artery disease. 
 
 Number of patients Mean score ± S.D. 
Occluded 5 26 ± 2 
Moderate Stenosis 7 24 ± 2 
Severe Stenosis 27 28 ± .8 
Total 39 27 ± .7 
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The Physical Performance Test (7-item) was also analyzed.  Although it was the goal of this 
project to include the ambulation on stairs categories on this test and report the 9-item scores, 
there were two patients who would not participate on the stairs for reasons not related to their 
cerebrovascular status.  One patient had recently recovered from a sprained ankle and opted not 
to do the stair tests, and another refused to do the stairs due to undefined “leg problems”.  Table 
10 is a summary of the 7-item PPT scores. 
Table 10:  Physical Performance Test (7-item) in patients with carotid artery disease. 
 
 Number of patients Mean score ± S.D. 
Occluded 5 22 ± 2 
Moderate Stenosis 7 19 ± 3 
Severe Stenosis 27 22 ± 3 
Total 39 21 ± 3 
 
As with the 9-item PPT, no subject reached a perfect score on the 7-item PPT of 28/28.  The 
range of scores for these patient groups was 19/28-22/28. 
5.2.3.  Instrumental Activities of Daily Living by Level of Severity 
The final outcome measure, instrumental activities of daily living, was measured by the Lawton 
IADL scale. Most scores, at 26/27 or 27/27, were very close to the maximum score of 27/27 
indicating independence in IADL’s.  Figure 8 is a histogram reflecting the distribution of the 
IADL scores. 
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Figure 8:  Histogram of Lawton IADL Scores for all Patients. 
 
Table 11 is a summary of the IADL scores by severity of disease for these patients. 
Table 11:  Instrumental activities of daily living in patients with carotid artery disease. 
 
 Number of patients Mean score ± S. D. 
Occluded 5 26 ± 1 
Moderate Stenosis 7 26 ± .6 
Severe Stenosis 27 27 ± .2 
Total 39 26 ± .2 
 
5.3.  Analysis by Side of Involvement in Carotid Artery Disease 
Another way to consider the outcomes for these patients with carotid artery disease is to look for 
differences in function based on the sidedness of the brain involvement.  Thus, data of the 39 
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patients was analyzed comparing the location of the lesion as being right, left or both sides 
involved.  There were 14 patients with right side involvement, 13 patients with left side 
involvement, and 12 patients with bilateral disease.  Table 12 is a summary of the descriptive 
data for the outcome measures based on side of involvement. 
Table 12:  Descriptive Data for RBANS, EXIT, PPT, IADL Measures Based on Location of 
Lesion. 
 
 Outcome measure Mean ± S.D. 
RBANS immediate memory 92 ± 20 
RBANS visuospatial/constructional 83 ± 19.2 
RBANS language 102 ± 16.2 
RBANS attention 96 ± 18.5 
RBANS delayed memory 94 ± 20 
RBANS total scale 92 ± 21 
EXIT Score 10 ± 5.9 
PPT 28 ± 5.3 
Right Side (n = 14) 
IADL 26 ± 1.5 
RBANS immediate memory 82 ± 16.7 
RBANS visuospatial/constructional 73 ± 13.8 
RBANS language 91 ± 11.8 
RBANS attention 85 ± 15 
RBANS delayed memory 85 ± 12 
RBANS total scale 79 ± 12.6 
EXIT Score 11 ± 5.7 
PPT 28 ± 2.8 
Left Side (n = 13) 
IADL 27 ± 1.1 
RBANS immediate memory 86 ± 21.9 
RBANS visuospatial/constructional 71 ± 9.2 
RBANS language 92 ± 10 
RBANS attention 83 ± 15.3 
RBANS delayed memory 84 ± 17.7 
RBANS total scale 78 ± 12.1 
EXIT Score 9 ± 4 
PPT 26 ± 4.4 
Both Sides (n = 12) 
IADL 26 ± 1.4 
 
An ANOVA was performed to identify if these 3 groups were different on any of the outcome 
measures (Table 13). 
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Table 13:  ANOVA table of between group differences for location of lesion in patients with 
carotid artery disease. 
 
 Sum of 
Squares 
df Mean 
Square 
F Sig. 
RBANS immediate memory 
  Between Groups 
  Within Groups 
  Total 
774.566
13816.101
14590.667
2
36
38
 
387.283 
383.781 
 
1.009 .36
RBANS visualspatial/constructional 
  Between Groups 
  Within Groups 
  Total 
1068.119
8012.804
9080.923
2
36
38
 
534.060 
222.578 
 
2.399 .11
RBANS language  
  Between Groups 
  Within Groups 
  Total 
856.917
6368.519
7225.436
2
36
38
 
428.458 
176.903 
 
2.422 .10
RBANS attention 
  Between Groups 
  Within Groups 
  Total 
1216.382
9725.054
10941.436
2
36
38
 
608.191 
270.140 
 
2.251 .12
RBANS delayed memory 
  Between Groups 
  Within Groups 
  Total 
854.190
10329.400
11183.590
2
36
38
 
427.095 
286.928 
 
1.489 .24
RBANS total scale 
  Between Groups 
  Within Groups 
  Total 
1624.863
9228.112
10852.974
2
36
38
 
812.431 
256.336 
 
3.169 .05*
EXIT Score 
  Between Groups 
  Within Groups 
  Total 
16.843
1016.900
1033.744
2
36
38
 
8.422 
28.247 
 
.298 .74
Physical Performance Test (9-item total)
  Between Groups 
  Within Groups 
  Total 
23.489
677.588
701.077
2
36
38
 
11.745 
18.822 
 
.642 .54
Lawton IADL 
  Between Groups 
  Within Groups 
  Total 
2.036
65.400
67.436
2
36
38
 
1.018 
1.817 
 
.560 .58
* p<.05 
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In this analysis, for the specific cognitive domains, no difference was found between the groups 
with different sides of carotid artery disease, or both sides involved with carotid artery disease.  
However, the cognitive domains of visuospatial/constructional, and language were approaching 
significance with p values of p< .11, p< .10 and the RBANS total scale was significant p< .05 
respectively.  None of the other outcome measures were significantly different. 
5.3.1.  Cognitive Test Results by Side of Involvement 
A one-sample t-test was conducted using right, left and both sides of involvement and was 
compared to cognition.  Again, there were significant differences from the normal scores of 
cognitive function identified (Table 14). 
Table 14:  One-tailed t-test for cognitive function based on side of involvement. 
 
 RBANS DOMAIN t –value Significance  
(1-tailed, p<.05) 
Immediate Memory -1.457 .09 
Visuospatial/constructional -3.381 .00* 
Language .338 .37 
Attention -.881 .20 
Delayed memory -1.089 .15 
Right Side 
n = 14 
Total Scale -1.492 .08 
Immediate Memory -3.970 .00* 
Visuospatial/constructional -7.029 .00* 
Language -2.656 .01* 
Attention -3.584 .00* 
Delayed memory -4.617 .00* 
Left Side 
n = 13 
Total Scale -6.138 .00* 
Immediate Memory -2.268 .02* 
Visuospatial/constructional -11.071 .00* 
Language -2.680 .01* 
Attention -3.836 .00* 
Delayed memory -3.119 .00* 
Both Sides 
n = 12 
Total Scale -6.340 .00* 
* p<.05 
From these data it was apparent that persons with either both carotid arteries affected, or the left 
side involved, cognitive function was impaired as compared to the normal scores in all cognitive 
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domains measured with the RBANS (p<.05).  Patients with right side involvement demonstrated 
significant impairment in visuospatial/constructional abilities (p<.00), and immediate memory 
and total scale domains were approaching significance (p<.09, p<.08 respectively).  The side of 
involvement was not a significant factor in the other outcome measures of executive function, 
physical function on the PPT and the Lawton IADL scale. 
5.4.  Correlations between Outcome Variables 
 
A Pearson’s correlation coefficient was calculated to determine the relationships between 
cognitive function and IADL ability (Table 15). 
Table 15:  Relationship between cognitive function and IADL's. 
 
 RBANS 
Total 
Scale 
 
Lawton 
IADL 
EXIT 
Score 
RBANS Total Pearson Correlation Scale
  Sig. (2-tailed) 
  N 
 
1
.
39
.023 
.890 
39 
-.57*
.000
39
Lawton IADL Pearson Correlation 
  Sig. (2-tailed) 
  N 
 
.023
.890
39
1 
. 
39 
-.42*
.008
39
EXIT Score Pearson Correlation 
  Sig. (2-tailed) 
  N 
 
-.57*
.000
39
-.42* 
.008 
39 
1
.
39
 
There was not a significant correlation between the RBANS and the Lawton IADL scale.  
However, there was a moderately strong137 negative correlation between the RBANS total scale 
and the EXIT measure of executive function (r = -.57).  The EXIT also was moderately 
negatively correlated with the Lawton measure of IADL (r=-.42). 
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5.4.1.  Correlations between Co-morbidities and Medications and Outcome Variables 
Pearson correlation coefficients were also calculated to determine a relationship between the 
number of comorbidities of the patients and their performance on the RBANS total scale score, 
the EXIT, the PPT (9-item and 7-item), and the Lawton IADL scores.  The same calculations 
were performed to determine a relationship between the effects of number of medications and 
performance.  No significant correlations were found. 
5.5.  Detailed Analysis of Timed Items on the Physical Performance Test 
 
The Physical Performance Test items were timed for performance.  A detailed analysis of each of 
the items was also conducted.  Table 16 is a summary of the items for all the patients tested. 
Table 16:  Physical Performance Timed Items for Patients with Asymptomatic Carotid Artery 
Disease.
 
(n = 39) 
Mean 
seconds ± 
S.D. Range 
Normal PPT time 
(for score= 4) 
Sentence writing 15.13 ± 6 8.7 – 35.9 ≤10 sec
Eating (simulated) 13.87 ± 3 9.3 – 19.2 ≤10 sec
Lifting a book 2.03 ± 1 .8 – 7.5 ≤  2 sec
Put on jacket 14.17 ± 4 7.7 – 26.3 ≤10 sec
Pick up penny 4.05 ± 4 1.8 – 26.7 ≤  2 sec
50’ Walk 15.93 ± 4 0 – 25.5 ≤15 sec
Climb one flight stairs 7.28 ± 3 0 – 20.6 ≤  5 sec
 
5.5.1.  Analysis of the PPT Timed Items and the Level of Severity of Carotid Stenosis 
Further analysis was done to see if there was a difference on any PPT item based on the  
severity of the carotid artery disease.  Table 17 is the data for each timed item based on the 
severity groups. 
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Table 17:  Physical Performance results on time items for patients with moderate, severe carotid 
artery stenosis or occlusion. 
Item 
(Time for score = 4) Group 
Mean 
±S.D. Range 
Sentence writing unilateral stenosis mod (n=3) 18.9 ± 2  16.8 – 20.8 
(</= 10 sec) unilateral stenosis severe (n = 18) 14.0 ± 6 8.7 – 35.9 
  unilateral occlusion (n = 3) 16.5 ± 9 11.2 – 26.7 
  bilateral stenosis mod (n = 4) 14.5 ± 3 12.3 – 18.5 
  bilateral stenosis severe (n = 9) 15.5 ± 5 9.2 – 24.5 
  bilateral occlusion (n = 2) 16.8 ± 4 14.1 – 19.7 
Eating (simulated) unilateral stenosis mod 18.2 ± .8 17.7 – 19.1 
(</= 10 sec) unilateral stenosis severe 13.3 ± 3 9.5 – 18.6 
  unilateral occlusion 13.4 ± .7 12.6 – 14 
  bilateral stenosis mod 16.2 ± 3 13.2 – 19.1 
  bilateral stenosis severe 13.5 ± 3 9.3 – 16.5 
  bilateral occlusion 10.6 ± .8 10 – 11.1 
Lifting a book unilateral stenosis mod 1.6 ± .7 1.2 – 2.5 
(</= 2 sec) unilateral stenosis severe 2.0 ± .6 .1 – 3.5 
 unilateral occlusion 2.5 ± 1 1.8 – 3.8 
  bilateral stenosis mod 2 ± .6 1.5 – 2.8 
  bilateral stenosis severe 2 ± 1 .76 – 5.5 
  bilateral occlusion 4.1 ± 5 .79 – 7.4 
Put on jacket unilateral stenosis mod 20.8 ± 5 16.2 – 26.3 
(</= 10 sec) unilateral stenosis severe 14.5 ± 4 7.7 – 22.8 
  unilateral occlusion 13.6 ± 3 10.9 – 16.2 
  bilateral stenosis mod 13.1 ± 2 11.5 – 16.4 
  bilateral stenosis severe 12.7 ± 3 8.0 – 16.9 
  bilateral occlusion 10.7 ± 4 8.0 – 13.3 
Pick up penny unilateral stenosis  mod 11.4 ±13  3.5 – 26.7 
(</= 2 sec) unilateral stenosis severe 3.5 ± 2 2.0 – 11.1 
  unilateral occlusion 2.9 ± .5 2.5 – 3.5 
  bilateral stenosis mod 3.7 ± 1 2.5 – 5.4 
  bilateral stenosis severe 3.6 ± 2 2.2 – 8.0 
  bilateral occlusion 2.1 ± .5 1.8 – 2.5 
50’ Walk unilateral stenosis mod 18.5 ± 6 14.8 – 25.5 
(</= 15 sec) unilateral stenosis severe 16.3 ± 3 12.4 – 24.5 
  unilateral occlusion 16.6 ± .4 16.3 – 17.0 
  bilateral stenosis mod 16.0 ± 3 12.7 – 19.5 
  bilateral stenosis severe 13.1 ± 5 .00 - 18 
  bilateral occlusion 19.8 ± 3 17.7 – 21.9 
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Climb one flight of stairs unilateral stenosis mod 5.1 ± 4 .00 – 7.7 
 (</= 5 sec) unilateral stenosis severe 7.8 ± 2 5.4 – 11.9 
 unilateral occlusion 6.4 ± .3 6.2 – 6.7 
  bilateral stenosis mod 7.9 ± 2 5.8 - 10 
  bilateral stenosis severe 6.4 ± 3 .00 – 9.5 
  bilateral occlusion 10.3 ± 
15 .00 
 mod: moderate 
An analysis of all 6 patient groups demonstrated a significant difference on 3 of the timed tasks.  
An ANOVA test demonstrated that there were significant differences between the groups on the 
three PPT timed items. (Table 18) 
Table 18:  ANOVA table for between group differences on the 7-item PPT. 
ANOVA 
 
    
Sum of 
Squares df Mean Square F Sig. 
Sentence writing Between Groups 77.884 5 15.577 .471 .80
  Within Groups 1092.418 33 33.104   
  Total 1170.303 38     
Eating (simulated) Between Groups 107.406 5 21.481 3.570 .01*
  Within Groups 198.542 33 6.016   
  Total 305.948 38     
Lift a book Between Groups 9.915 5 1.983 1.320 .28
  Within Groups 49.560 33 1.502   
  Total 59.475 38     
Put on jacket Between Groups 183.599 5 36.720 2.847 .03*
  Within Groups 425.632 33 12.898   
  Total 609.231 38     
Pick up penny Between Groups 179.847 5 35.969 2.584 .04*
  Within Groups 459.287 33 13.918   
  Total 639.134 38     
50’ Walk Between Groups 123.199 5 24.640 1.677 .17
  Within Groups 484.990 33 14.697   
  Total 608.188 38     
Climb one flight stairs Between Groups 48.868 5 9.774 .878 .51
  Within Groups 367.373 33 11.133   
  Total 416.240 38     
* p < .05 
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The three tasks of simulated eating, putting on a jacket and picking up a penny were all 
significantly different within the groups at the p<.01, p< .03 and p< .04 levels.  A Tukey post hoc 
comparison was completed and revealed that the unilateral moderate stenosis group had a higher 
mean than the other groups for all 3 tasks, simulated eating, picking up a penny and putting on a 
jacket. 
 
An analysis was also done combining the 6 patient groups by severity of disease into 3 groups, 
unilateral and bilateral moderate stenosis, unilateral and bilateral severe stenosis and unilateral 
and bilateral occlusion.  (Table 19) 
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Table 19:  ANOVA table for between group differences for the timed PPT items, based on 
severity of carotid disease. 
ANOVA 
 
    
Sum of 
Squares df 
Mean 
Square F Sig. 
Sentence writing Between Groups 32.431 2 16.216 .513 .60
  Within Groups 1137.872 36 31.608   
  Total 1170.303 38     
Eating (simulated) Between Groups 90.320 2 45.160 7.540 .00*
  Within Groups 215.628 36 5.990   
  Total 305.948 38     
Lifting a book Between Groups 6.612 2 3.306 2.251 .12
  Within Groups 52.863 36 1.468   
  Total 59.475 38     
Put on jacket Between Groups 52.083 2 26.042 1.683 .20
  Within Groups 557.148 36 15.476   
  Total 609.231 38     
Pick up penny Between Groups 79.269 2 39.635 2.549 .09
  Within Groups 559.865 36 15.552   
  Total 639.134 38     
50’ Walk Between Groups 39.254 2 19.627 1.242 .30
  Within Groups 568.935 36 15.804   
  Total 608.188 38     
Climb one flight stairs Between Groups 4.894 2 2.447 .214 .81
  Within Groups 411.347 36 11.426   
  Total 416.240 38     
* p < .05 
Simulated eating was the only item that was significantly different (p<.00) between the levels of 
severity.  Tukey post hoc comparisons revealed that the moderately stenotic group had a 
significantly higher mean than the severely stenotic and occluded groups.  Thus, these subjects 
took significantly longer on the simulated eating task.  This is a consistent finding with the 
previous analysis of the 6 groups. 
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5.5.2.  Analysis of the PPT Timed Items and the Side of Carotid Disease 
 
In an analysis of the 7 timed items looking for differences based on location of the lesion, right 
ICA, left ICA or both sides, there were no significant differences found on any of the items at the 
p<.05 level. 
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VI.  Conclusion: 
 
This was a prospective observational study that was designed to address 2 specific aims: 1) to 
determine if patients with asymptomatic carotid artery disease of a moderate severity or greater 
demonstrate deficits in cognitive and physical function and 2) to determine if there was a 
correlation between the cognitive measures (RBANS and EXIT) and the patients’ performance 
of instrumental activities of daily living. 
 
It was found that patients with a moderate or severe degree of stenosis or an occluded carotid 
artery did have deficits in multiple cognitive domains, as assessed by the RBANS.  There was 
not a significant difference if the disease was unilateral or bilateral, thus severity of disease was 
the category examined.  However, there was a difference in cognitive function based on laterality 
of disease, and it appeared that patients with left sided and bilateral disease demonstrated deficits 
in more cognitive domains than the patients with right sided disease, who mainly demonstrated 
deficits in the visuospatial/constructional domain.  The cognitive domain of executive function, 
as assessed via the EXIT was not found to be impaired in the study.   
 
We also determined that physical performance as assessed via the PPT 9-item, 7-item tests and 
the 7 timed tasks were impaired, with all patient subgroups demonstrating sub-maximal scores 
on the tests.  A sub-maximal score could be interpreted as an early indicator of preclinical 
disability and could suggest that the patient was not functioning optimally.  In further analysis of 
the PPT results, the individual tasks of the test were timed, in order to determine if a certain task 
was difficult for persons with asymptomatic carotid artery disease.  The task of simulated eating, 
a fine motor coordination task, was the task that was identified as taking the most time in the 
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moderately stenotic subgroup of patients.  The researchers suggest that this poorer performance 
on the PPT might be interpreted as a “symptom” in these reportedly asymptomatic patients. 
 
With the Lawton Instrumental Activities of Daily Living assessment there was not a deficit in 
functional performance demonstrated in any of the patient subgroups.  The researchers observed 
that for this population the assessment tool demonstrated a ceiling effect. 
 
The second aim of the study was to correlate the patients’ cognitive performance with 
performance of instrumental activities of daily living as assessed via the Lawton IADL scale.  
We did not find a relationship between cognitive function as assessed via the RBANS scale, 
however there was a moderately strong negative correlation between cognitive executive 
function as assessed via the EXIT and the Lawton IADL scale.  The researchers concluded that 
the impairments noted in the detailed cognitive examination of the RBANS were not severe 
enough to have affected the more general activities assessed by the Lawton.  Additionally, the 
Lawton was a self-report assessment tool, and these patients were not reporting any difficulties 
on clinical examination. 
 
In conclusion, patients with asymptomatic carotid artery disease (moderately, severely stenotic 
or occluded) demonstrated deficits on the RBANS measure of cognitive function and on the 
Physical Performance Test.  In addition, the EXIT assessment and IADL function were 
negatively correlated, whereas the RBANS and the Lawton IADL assessment were not 
correlated.  Regarding the identified cognitive deficits, it cannot be unrecognized that these 
deficits in this patient sample may be related to other conditions that can impair cognition that 
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have not been identified in this study.  From this study, it is concluded that patients with carotid 
artery disease who are reportedly asymptomatic on clinical examination, when evaluated in 
greater detail might have symptoms that should be considered in the overall assessment and plan 
for intervention for the carotid artery disease and risk of stroke. 
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VII.  Cognitive and Physical Performance in Patients with Asymptomatic Carotid Artery 
Stenosis and Occlusion 
 
Abstract 
 
Background and Purpose:  The purpose of this study was to determine if patients with 
asymptomatic carotid artery stenosis and occlusion demonstrate deficits in cognitive and 
physical performance.  The relationship between cognitive measures and performance of 
instrumental activities of daily living was examined. 
Methods:  Thirty-nine patients with asymptomatic carotid artery stenosis of moderate and severe 
degrees, or occlusion were tested.  Cognition was assessed via the Repeatable Battery for the 
Assessment of Neuropsychological Status (RBANS) and the Executive Interview (EXIT).  
Physical performance was assessed via the Physical Performance Test (PPT), and the Lawton 
Instrumental Activities of Daily Living. 
Results:  Deficits in cognitive function were found on the RBANS for all levels of stenosis and 
occluded subgroups in the domains of visuospatial/constructional and delayed memory, in the 
moderate stenosis subgroup in immediate memory, attention and visuospatial/constructional, and 
in the severe subgroup in all domains except language.  There were no significant findings on the 
EXIT.  Decreased performance on the PPT was identified in all 3 subgroups.  The Lawton IADL 
did not identify any decrease in performance. 
Conclusions:  Deficits in cognitive and physical function were found in this observational study 
of patients with asymptomatic carotid artery stenosis and occlusion, indicating that asymptomatic 
patients may not be truly asymptomatic.  This potential change in status needs to be considered 
as patients are being evaluated for interventions to manage their carotid artery disease.  
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Introduction 
 
In asymptomatic patients with carotid artery stenosis and occlusion, stroke risk is not clear. 
Autret et.al. followed 242 asymptomatic patients for approximately 2.5 years and determined a 
.23% risk of stroke in patients with a low amount of stenosis, 2.48% risk in patients with 
moderate stenosis, and 1.71% risk in severe stenosis.8  Other investigators have found similar 
low risk in these patients.10  However, in the Asymptomatic Carotid Artery Study (ACAS), the 
researchers recommended that in asymptomatic carotid artery disease of 60% stenosis or greater, 
the procedure of a carotid endarterectomy  in patients with good general health can help to 
reduce the risk of a stroke occurring on the ipsilateral side of the brain by 53% over 5 years.19  
Carotid endarterectomy is the intervention of choice in situations of high-grade (greater than 
90%) asymptomatic carotid artery stenosis.53  In asymptomatic patients with carotid artery 
occlusion, Hennerici et.al. determined a stroke risk of 16%, and a TIA incidence of 10% in 49 
asymptomatic occluded patients over a 31.2 month period.11 In contrast, studies by Power et al. 
al. and Bornstein and Norris found minimal risk of stroke (less than 3%) in asymptomatic 
patients with occlusion.12,13  
 
The identification of asymptomatic patients is not as clear as symptomatic patients.  There are no 
obvious clinical findings, and often the stenotic or occluded carotid artery is found as an 
incidental finding during a medical work-up.  It is suspected that subtle physical, cognitive or 
emotional changes in function could occur due to disruption of the blood flow to the brain that is 
not recognized by the patient.  It is the purpose of this research study to determine if patients 
with asymptomatic carotid artery stenosis and occlusion, demonstrate deficits in cognitive and 
physical performance measures.  The study attempts to determine if there is a correlation 
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between the cognitive functions and the patient’s ability to complete instrumental activities of 
daily living (IADL’s). 
Methods: 
 
Thirty-nine patients with asymptomatic carotid artery disease participated and were recruited 
from the Neurosurgery clinic at the University of Pittsburgh Medical Center.  After the study was 
explained and consent was obtained, the patients were divided into six subgroups; unilateral and 
bilateral moderate stenosis (50-69%), unilateral and bilateral severe stenosis (70-99%) and 
unilateral and bilateral occlusion, based on the computed tomographic arteriography (CTA) scan, 
magnetic resonance imaging (MRI) study or carotid doppler study as read by the neurosurgeon.  
The patients were often referred to the neurosurgeon for evaluation of the status of the carotid 
artery pathology.  Asymptomatic status was determined by patient report during the history and 
the clinical examination.  Patients were excluded from the study if they had a history of stroke, 
dementia as determined by the physician, were unable to speak English and answer questions, 
were precluded from weight bearing due to an orthopedic condition, or had severe 
cardiopulmonary compromise. 
 
The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS)119 and the 
EXIT120 were used to measure cognition.  The RBANS is a recently developed test battery that is 
recognized as a clinically useful tool to rapidly screen neuropsychological status in the acute care 
setting to help guide medical and surgical decision making regarding cognitive status.121  It was 
developed to characterize cognitive decline in older adults, and serve as a screening battery for 
younger patients.  The test assesses 5 domains of cognitive function including immediate 
memory, visuospatial/constructional, language, attention and delayed memory.  Scoring on the 
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test has been standardized in age groups with a mean score of 100 and standard deviation of 15 
points as the standard score.  The test has been shown to be reliable for all age groups with an 
overall total reliability score of .94121 and has been found to be a valid test in a mixed adult 
population with a variety of neuropsychological problems.121  The sensitivity and specificity of 
the test to the detection of dementia was found to be 90%..119  The test was chosen for this study 
due to its ease of use and its ability to screen cognition within very definitive domains. 
 
The EXIT test was used to assess the sixth cognitive domain of executive function.  Executive 
function is the process of orchestrating relatively simple actions such as movements or ideas into 
goal-directed behaviors.138  The 25-item tool has demonstrated high internal consistency 
(Cronbach’s alpha = .87).  It was shown in a pilot study to be valid and reliable to assess 
executive function and discriminate between different functional levels of persons tested and the 
severity level of their dementia.120 
 
The Physical Performance Test (PPT) 9-item was used to assess physical function.122  This test is 
a global measure of physical performance that assesses basic and complex activities of daily 
living (ADL’s).122  The test includes the items: writing a sentence, simulated eating, donning and 
doffing a jacket, 360 degree turn right and left, lifting a book to a shelf, picking up a penny from 
the floor, walking 50 feet, climbing one flight of stairs, climbing several flights of stairs (4 
maximum).  The PPT 9-item test has been shown to demonstrate internal consistency 
(Cronbach’s alpha = .87) and interrater reliability (r = .99) in older adults.122  In preparation for 
the study, the primary invesigator demonstrated strong interrater reliability (r=.92) with an 
experienced researcher who uses the PPT.  
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The Lawton Instrumental Activities of Daily Living Scale (IADL)113  requires the patient to 
report if they are independent, need assistance, or are unable to complete the instrumental ADL 
skills.  The Lawton IADL scale has been found to be valid and practical for use in a variety of 
elderly age groups.113  Patients were tested once by a trained investigator.  
Statistical Analysis 
 
Descriptive data were collected on the demographic data of the patients, their medications, 
comorbidities and all the outcome tools (RBANS, EXIT, PPT, IADL).  An analysis of variance 
(ANOVA) was used to determine if there were significant differences between the 6 patient 
groups based on severity of disease, unilateral vs. bilateral involvement, and also on laterality of 
the disease (left side vs. right side vs. both sides involved).  A one-tailed t-test was used to 
determine if there was a difference in any of the RBANS cognitive measures from the 
established normal score.  The use of a one-tail test was due to the expectation of a decline in 
function for the patient.  The mean EXIT score for executive function was calculated for each 
group and compared to the recommended cut-off score of 15/50, with higher scores indicating 
greater executive dysfunction.120,139  Similarily, the mean 9-item PPT score and the Lawton 
IADL score were calculated and compared to the maximum scores of 36/36 and 27/27 
respectively.  A lower score indicates that a person needs more time to complete a task on the 
PPT, or assistance with a task on the IADL, thus suggesting the beginning of a physical decline, 
and a possible status of preclinical disability.124,140  Correlations were calculated between the 
cognitive scores (RBANS and EXIT scores) and the Lawton IADL scores via Pearson’s 
Correlation coefficients. 
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Results: 
 
Thirty-nine patients with asymptomatic carotid artery disease were tested (Table 20).  
Table 20:  Diagnostic groups by gender, age and side affected in patients with asymptomatic 
carotid artery disease. 
Diagnostic Group Gender Mean Age 
(yrs.) ± 
Standard 
Deviation 
Age Range    Side 
Involved 
 (R=right 
  L=left 
  B=both) 
Unilateral Stenosis 
Moderate 
n = 3, (7.7%) 
2 male    (67%) 
1 female (33%) 
78  ± 6.23 71-83 2 – R 
1 – L 
Unilateral Stenosis  
Severe 
n = 18, (46.2%) 
11 male  (61%) 
7 female (39%) 
75  ±7.65 55-87 6 – R 
8 – L 
Unilateral Occlusion 
n = 3, (7.7%) 
2 male    (67%) 
1 female (33%) 
63  ± 15.5 48-79 2 – R 
1 – L 
Bilateral Stenosis 
Moderate 
n = 4, (10.3%) 
3 male    (75%) 
1 female (25%) 
76  ± 8.14 66-85 2 – L 
2 – B 
Bilateral Stenosis 
Severe 
n = 9, (23.1%) 
5 male    (56%) 
4 female (44%) 
73  ± 5.48 64-79 1 – L 
8 – B 
Bilateral Occlusion 
n = 2, (5.1%) 
1 male    (50%) 
1 female (50%) 
63  ± 4.95 59-66 2 – B 
All patients  
(n = 39) 
23 male    (59%) 
16 female (41%) 
73 ± 8.49 48-87 years 14 – R 
13 – L 
12 – B 
 
The sample was slightly dominant for males, with a mean age of 73 years (48-87).  Most patients 
(70%) tested in this study were severely stenotic, with another 13 % occluded, and the remaining 
17% had moderate carotid artery stenosis.  Patients with bilateral involvement were grouped into 
the side of stenosis that the surgeon would be considering for surgery.  In situations when the 
level of stenosis was the same, or occlusion existed bilaterally, then the patient was classified 
with bilateral disease.  For the 39 patients, there were 14 right side, 13 left side and 12 with 
bilateral involvement.
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The most common comorbidities that the patients had were hypertension (38.5%), 
hypercholesteremia (36%) diabetes mellitus (33.3%) coronary artery disease (30.8%), and 
cardiac arrhythmia (12.8%).  There were a wide variety of medications being taken.  The most 
common categories of medications were the CNS agents which included 5 different medications, 
the antihypertensives and the antilipemics.  The 2 most common medications were aspirin 
(54%), and the antilipemic Zocor (26%). 
 
With the 39 patients, the ANOVA revealed no significance differences between the groups 
(unilateral or bilateral moderate, severe disease, or occlusion) on any of the outcome measures.  
Because no significant differences between the groups were found at the p<.05 level and due to 
the small sample size, the asymptomatic patients with unilateral and bilateral moderate, unilateral 
and bilateral severe, or unilateral and bilateral occluded carotid artery disease were considered 
together for the rest of the remaining data analysis.   
 
On the RBANS cognitive test, a one-sample, one-tailed t-test was used to determine if these 
results were significantly different from the established normal score (100).  A one-tailed test 
was used as the investigators were attempting to determine if the subjects had cognitive decline.  
All 3 subgroups demonstrated a minimum of 3 cognitive areas of significant deficit as compared 
to normal values.  Individual domain scores ranged from 84-98 in the occluded group, 67-90 in 
the moderate stenosis group and 84-97 in the severe stenosis group.  Table 21 is a summary of 
the RBANS mean scores and the t-test results. 
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Table 21:  RBANS Scores, means, standard deviations, and t-test results based on level of 
stenosis. 
Severity 
 
RBANS DOMAIN Mean t – value Significance 
(1-tailed, *p<.05) 
Occluded Immediate Memory 98 ± 15.6 -.344 .37 
Visuospatial/constructional 77 ± 10.71 -4.717 .00* 
Language 94 ± 9.01 -1.439 .11 
Attention 87 ± 15.4 -1.858 .07 
Delayed memory 86 ± 10.84 -2.888 .03* 
n = 5 
Total Scale 86 ± 10.5 -3.066 .02* 
Moderate 
Stenosis 
Immediate Memory 84 ± 18.66 -2.309 .03* 
Visuospatial/constructional 67 ± 9.31 -9.503 .00* 
Language 90 ± 14.64 -1.807 .06 
Attention 79 ± 12.38 -4.520 .00* 
Delayed memory 87 ± 18.71 -1.798 .06 
n = 7 
Total Scale 76 ± 13.41 -4.818 .00* 
Severe 
Stenosis 
Immediate Memory 85 ±  20.41 -3.716 .00* 
Visuospatial/constructional 78 ± 16.85 -6.831 .00* 
Language 97 ± 14.34 -1.154 .13 
Attention 91 ± 17.83 -2.656 .01* 
Delayed memory 88 ± 18.17 -3.315 .00* 
n = 27 
Total Scale 84 ± 18.45 -4.370 .00* 
 
In the occluded subgroup, significant cognitive deficits were found in the visuospatial/ 
constructional (mean score 77, p<.00) and delayed memory domains (mean score 86, p<.03).  In 
the moderately stenotic subgroup, there was significant cognitive decline in the immediate 
memory (mean score 84, p<.03), visuospatial/constructional (mean score 67, p<.00), and 
attention (mean score 79, p<.00) domains. In the severely stenotic subgroup, there was 
significant cognitive deficit in all domains; immediate memory (mean score 85, p<.00), 
visuospatial/constructional (mean score 78, p<.00), attention (mean score 91, p<.01), delayed 
memory (mean score 88, p<.00) with the exception of language.  All subgroups showed a 
significant cognitive decline on the RBANS total scale score, (p<.02 in the occluded subgroup), 
p<.00 for the moderate and severe stenosis subgroups). 
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For the cognitive domain of executive function, mean scores for each severity group were 
compared to the recommended cut-off score of 15/50..120  All mean scores for the groups were 
below this level (occluded 10/50, moderate stenosis 13/50, and severe stenosis 9/50) indicating 
no executive dysfunction. 
 
With the PPT, no patient reached a perfect score of 36/36.  For all 39 patients, scores ranged 
from 19/36 – 30/36 with a mean score of 27/36.  By severity group, the PPT mean scores were: 
occluded 26/36, moderate stenosis 24/36 and severe stenosis 28/36. 
 
The final outcome measure, instrumental activities of daily living, was measured by the Lawton 
IADL scale. Eighty-seven percent of the scores, at 26/27 or 27/27, were very close to the 
maximum score of 27/27 indicating independence in IADL’s.  By severity group, the IADL 
mean scores for the occluded and moderate stenosis were 26/27, and severe stenosis 27/27. 
 
An ANOVA was performed to identify if patients with right (n = 14), left (n = 13) and bilateral 
involvement (n=12) were different on any of the outcome measures.  No difference was found 
between the groups with different sides of carotid artery disease, or both sides involved with 
carotid artery disease.  However, the RBANS domains of visuospatial/constructional, and 
language were approaching significance with p values of p< .11, p< .10 and the RBANS total 
scale was significant p< .05 respectively.  None of the other outcome measures (EXIT, PPT, 
Lawton IADL) were significantly different. 
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Laterality of brain involvement (right, left and both sides) was compared to the normal 
standardized cognitive score for the RBANS by a one-sample t-test.  Significant differences from 
the normal standardized score (100) were found for most of the cognitive domains. (Table 22) 
Table 22:  RBANS scores by location of lesion group, and t-test results. 
 RBANS DOMAIN Mean t – value Significance 
(1-tailed, *p<.05) 
Right Side Immediate Memory 92 ± 20 -1.457 .09 
Visuospatial/constructional 83 ± 19.21 -3.381 .00* 
Language 102 ± 16.23 .338 .37 
Attention 96 ± 18.5 -.881 .20 
Delayed memory 94 ± 19.96 -1.089 .15 
n = 14 
Total Scale 92 ± 20.95 -1.492 .08 
Left Side Immediate Memory 82 ± 16.7 -3.970 .00* 
Visuospatial/constructional 73 ± 13.81 -7.029 .00* 
Language 91 ± 11.8 -2.656 .01* 
Attention 85 ± 15.01 -3.584 .00* 
Delayed memory 85 ± 11.95 -4.617 .00* 
n = 13 
Total Scale 79 ± 12.61 -6.138 .00* 
Both Sides Immediate Memory 86 ± 21.89 -2.268 .02* 
Visuospatial/constructional 71 ± 9.18 -11.071 .00* 
Language 92 ± 10.02 -2.680 .01* 
n = 12 
Attention 83 ± 15.27 -3.836 .00* 
  
Persons with either both carotid arteries affected or the left side involved had impaired cognitive 
function as compared to the normal scores in all cognitive domains measured with the RBANS 
(p<.05).  Patients with right side involvement demonstrated significant impairment in 
visuospatial/constructional abilities (mean score 83, p<.00).  Also, immediate memory (mean 
score 92) and total scale (mean score 92) domains were approaching significance (p<.09, p<.08 
respectively).  The side of involvement was not a significant factor in the other outcome 
measures of executive function, physical function and IADL’s.  
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A Pearson’s correlation coefficient was calculated to determine the relationships between 
cognitive function and IADL ability.  There was not a significant correlation between the 
RBANS and the Lawton IADL scale.  However, there was a moderately strong negative 
correlation between the RBANS total scale and the EXIT measure of executive function  
(r = -.57).  The EXIT was moderately negatively correlated with the Lawton measure of IADL  
(r = -.42).   
Discussion: 
 
Patients with asymptomatic carotid artery disease display deficits in cognition and physical 
function which might indicate that they are symptomatic.  Analysis by severity of carotid disease 
revealed differences in the particular cognitive domains that were affected, however, 90 % of the 
patients were deficient in the visuospatial/constructional domain, and patients in the severe (70-
99%) stenosis group were deficient in all of the cognitive domains assessed with the exception of 
language.  Patients with occlusion showed deficits in delayed memory, and those with moderate 
stenosis demonstrated decline in immediate memory and attention.  Poor cognitive functioning 
was previously identified in a community sample of males 59-71 years old with moderate carotid 
artery stenosis61 consistent with our findings.  Because these persons were community dwelling, 
it is assumed that they were asymptomatic.  Cognition was evaluated by the Mini-Mental State 
Examination and seven additional neuropsychological tests that assessed attention, psychomotor 
rapidity, verbal abilities, memory and visuospatial perception.   
 
The issue of cognitive impairment in patients with severe symptomatic and asymptomatic carotid 
artery stenosis has been explored in patients undergoing carotid endarterectomy.99  An 
improvement on a neuropsychometric evaluation assessing higher cortical functions of fine 
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motor control, executive function and verbal memory was demonstrated after endarterectomy 
and improvement continued through the 5 month follow-up.99 
 
In our study, the cognitive scores of the RBANS were compared to age-matched standardized 
scores.  Rao studied cognitive changes in symptomatic severe carotid artery stenosis and also 
identified an association between neuropsychological impairment and stenosis.62  The study 
focused on frontal lobe function and results were compared to a control group.  One of the 
limitations of this study is that there is not a control group.  The choice of the RBANS allowed 
for comparisons with age-matched established normal scores.  Recently, Johnston et.al. 
identified that cognitive impairment and decline are associated with patients that have left-sided 
severe asymptomatic carotid artery stenosis.7  Our study analyzed cognitive function for left, 
right and both sides of involvement with moderate, severe and occluded levels of disease.  Our 
results are similar for the left sided involvement, and all cognitive domains on the RBANS 
demonstrated scores below the normal standard score.  Similarly, if a patient had bilateral 
involvement, then all cognitive domains were deficient.  If a patient had right-side involvement, 
only the visuospatial/constructional domain was found to be deficient.  This is reasonable, since 
visuospatial/constructional ability is primarily attributed to the right side of the brain.27 
 
Heyer et.al.demonstrated an improvement in executive function via the Halstead Trails A and B 
tests in the follow-up assessments after endarterectomy.99  Presently, there is no recognized gold 
standard for the evaluation of executive function.138  The EXIT was chosen in this study due to 
its comprehensiveness and “clinical friendliness”.  It takes less than 15 minutes to administer and 
can be easily administered in the clinic.  This study did not demonstrate that patients had 
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executive dysfunction based on the EXIT.  The lack of a significant finding in this area in this 
study may be due to the smaller sample size, or due to the EXIT being a more global measure of 
multiple executive function tasks as opposed to the Trails A and B, which are more specific to 
test the executive functions of visual conceptual and visuomotor tracking. 
 
In other studies that assessed physical or motor performance in patients with carotid artery 
disease, none used a test that would evaluate physical function from the perspective of simple 
and complex daily activity completion.98,99   The Physical Performance Test (9-item) identified 
slowed performance in all of the stenosis groups.122  A score less than 36/36 indicates that a 
slower performance of a task and is possibly suggestive of an early indicator of disability.124  
None of the patients reached a score of  36/36.  Mean scores for each stenosis subgroup 
demonstrated that the moderate stenosis subgroup revealed the largest deficit with a score of 
24/36, the severe stenosis subgroup 28/36 and the occluded subgroup 26/36.  These mean scores 
are far below the maximum desired score, suggesting that these patients are not asymptomatic.   
 
Our IADL measure was chosen because it has been shown that a person experiencing a decline 
in cognition has a related decline in IADL function.116-118  A decline in cognition has been 
specifically related to the domain of executive function.114,115  Pohjasvaara et.al. have suggested 
that complex ADL’s may be a more sensitive measure for early vascular impairment than basic 
ADL’s.115  Regardless of level of severity of stenosis or sidedness of involvement, all subjects 
scores ranged between 26 and 27 out of 27on the Lawton IADL scale.  There was a ceiling effect 
for the Lawton in this study, since greater than 15 % of the subjects reached the maximum score 
on the measure.141  There was a  moderately strong negative correlation between the EXIT and 
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the Lawton IADL (r = -.42).  As the patient’s score on the EXIT increased (indicating greater 
executive dysfunction), the IADL score decreased.   
 
A main intention of this study was to assess a patient’s clinical status in order to identify subtle 
indicators that patients may have previously experienced functional loss.  Influencing factors that 
might have confounded this study were the presence of cardiovascular comorbidities such as 
congestive heart failures, hypotension, cardiac arrythmias and coronary artery bypass graft.  
These conditions have been shown to relate to impaired cognition.63-65,67,70-72  In this study 31 % 
had coronary artery disease and 13% had cardiac arrhythmias.  However, we feel that this is still 
not a full explanation for the incidence of cognitive decline demonstrated in our patients.   
 
The amount of white matter changes that a patient may have displayed on computerized axial 
tomography (CT scan) or magnetic resonance imaging (MRI) was not assessed.  There is a 
relationship between white matter changes and cognitive decline in healthy, community-dwelling 
older people (70 and greater).142,143  The mean age of our patients was 73 years.  Consequently, 
in future studies, the use of CT scanning or PET studies to assess the amount of white matter 
involvement may be useful.   
 
Another issue in this study is the low number of patients (39) and the unevenness of patients in 
each stenotic subgroup.  However, the authors felt that the results were impressive enough to 
substantiate the argument that asymptomatic patients are not functioning optimally.  Substandard 
performance on the cognitive and physical tests may be considered a “symptom” for these 
patients, increasing their risk for stroke.  Following these asymptomatic patients over time might 
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help suggest whether any of the tools used can help to predict the incidence of stroke or TIA.  
Ferrucci et.al. studied patients 70 years old and older who were stroke free.  They found that 
impaired cognition was significantly associated with an increase risk for stroke, especially if the 
cognitive decline extended over a 3-year period.144 
 
In summary, deficits in cognitive and physical function were found in this descriptive study of 
patients with asymptomatic carotid artery disease.  Deficits in IADL’s were not pronounced in 
this group.  We suggest that neuropsychological assessment of higher level cognitive skills and a 
performance based measure of physical abilities should be included in the clinical examination 
of asymptomatic carotid artery disease patients that present with carotid artery stenosis of a 
moderate or greater level of severity. 
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VIII.  Use of the Physical Performance Test in Patients with Asymptomatic Carotid Artery 
Stenosis and Occlusion. 
 
Abstract 
 
Background and Purpose:  The purpose of this study was to determine if patients with 
asymptomatic carotid artery stenosis and occlusion demonstrate deficits in physical performance.  
Subjects:  Thirty-nine patients with asymptomatic carotid artery stenosis of moderate and severe 
degrees, or occlusion were tested.  Methods: Physical performance was assessed via the 9-item 
and 7-item Physical Performance Test (PPT).  Individual tasks were also timed.  Results:  
Patients with asymptomatic carotid artery stenosis and occlusion demonstrated less than optimal 
performance on the PPT ( 9-item, 27/36; 7-item 21/28).  Simulated eating was the slowest task to 
perform for the patients with moderate stenosis.  Discussion and Conclusion:  Patients with 
asymptomatic carotid artery stenosis and occlusion exhibit changes in function as indicated by 
their performance on the PPT.  This may be indicative of preclinical disability, and a potential 
symptomatic status of the patient. 
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Introduction 
 
The Physical Performance Test (PPT), developed by Reuben and Siu, was designed to be a direct 
observation method to assess multiple dimensions of physical function (basic and complex 
activities of daily living) of different levels of difficulty.122  The principle target population for 
the PPT was the elderly, and the original study tested patients from 49-94 years old with an 
average age of 79.122  The researchers advised that the PPT could be useful in the prediction of 
functional decline in patients.122  Direct observational assessment of function verses patient self-
report has suggested that direct observational assessment might provide more information 
regarding patient functional limitations than patients have reported.124,145 
 
The PPT has been used for the purpose of both measuring functional improvement and 
predicting functional decline in recent research studies.124,146  Brach et.al found that in 
community-dwelling older women (mean age 74.3 years) the PPT identified more physical 
limitations than self-report measures.  The researchers suggested that in a “high-functioning” 
sample of older women who had minor problems with functional tasks, that the PPT was more 
effective in identifying functional problems than self reports.124  The concept of preclinical 
disability has been offered to explain this situation.140  In preclinical disability, there is a 
progressive decline in physical function that goes unrecognized, and often times is predictive of 
a subsequent clinically recognizable functional decline.140  The change in function might include 
taking longer to complete a task, modifying a task in order to accomplish it, or not attempting a 
task as often.140,145  Fried has continued to suggest that a progressive, unnoted functional decline 
might be the result of disease progression.147  
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Similarly, this concept of a decline in function prior to patient reported decline has been the 
concern of health care providers working with patients with asymptomatic carotid artery disease.  
For people with asymptomatic carotid artery disease, the stroke risk has been found to be less 
dramatic than for the symptomatic patients.14,24,28,49,55  Thus, the medical management has been 
different, and patients are not as readily offered surgical intervention, such as a carotid 
endarterectomy, which has been shown to significantly reduce the risk of stroke in the 
symptomatic patients.28,48,50,51  Asymptomatic patients with carotid artery stenosis and occlusion 
are typically identified during routine physical examinations, or during medical work-up for 
another medical problem.  They are often referred to the neurologist or neurosurgeon to evaluate 
if further medical or surgical interventions are necessary.  If no clinical symptoms are reported 
by the patient, such as weakness, paralysis, numbness or tingling affecting a side of the body, 
word finding or word slurring problems, they are treated as asymptomatic.  However, if these 
types of things were occurring, they would impair physical performance.  It has been found that 
changes in physical, cognitive and emotional function escape being communicated in the clinical 
history and examination of patients with asymptomatic carotid artery disease.58  Therefore, the 
purpose of this study was to determine if patients with asymptomatic carotid artery stenosis and 
occlusion demonstrate deficits in physical performance.  This study was part of a larger study 
that considered cognitive function and instrumental activities of daily living as additional 
indicators of impaired function in these asymptomatic patients with carotid artery disease.  
Methods 
 
Subjects 
 
Thirty-nine consecutive patients with asymptomatic carotid artery disease participated and were 
recruited from the Neurosurgery clinic at the University of Pittsburgh Medical Center (UPMC).  
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The study received Internal Review Board approval by UPMC.  After the study was explained to 
the patient and consent was given, the patients were divided into three subgroups; unilateral and 
bilateral moderate stenosis (50-69%), unilateral and bilateral severe stenosis (70-99%) and 
unilateral and bilateral occlusion,28,49 based on the computed tomographic arteriography (CTA) 
scan, magnetic resonance imaging (MRI) study or carotid doppler study as read by the 
neurosurgeon .  Asymptomatic status was determined by patient report during the history and the 
clinical examination.  Asymptomatic patients are often referred to the neurologist or 
neurosurgeon for an additional medical opinion due to the incidental finding of the carotid artery 
disease when worked-up for another medical issue or during routine physical examinations.  
Patients were excluded from the study if they had a history of stroke, dementia as determined by 
the physician, were unable to speak English and answer questions, or were precluded from 
weight bearing due to an orthopedic condition, or had severe cardiopulmonary compromise. 
Measures 
 
The Physical Performance Test (PPT) 9-item and 7-item, were used to assess physical function 
and the 7 timed tasks were also analyzed individually.122  The PPT is a global measure of 
physical performance that assesses basic and complex activities of daily living (ADL’s).122  The 
9-item test includes the items: writing a sentence, simulated eating, donning and doffing a jacket, 
360 degree turn right and left, lifting a book to a shelf, picking up a penny from the floor, 
walking 50 feet, climbing one flight of stairs, climbing several flights of stairs (4 maximum).  In 
the 7-item test, the tasks of climbing one flight of stairs and several flights of stairs were 
eliminated from the scoring.  The test was administered and scored according to the protocol 
from its originators.122  Test items were timed with a standard stop watch and rounded off to the 
nearest tenth of a second.  The time of task completion was recorded.  Also, time was also 
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rounded to the nearest 0.5 second and was converted into the ordinal scale (0-4) as suggested in 
the original test.122  On the PPT 9-item a score of 36/36 is the highest score possible, and would 
be considered normal function.  On the 7-item test this score is 28/28.  Scores below this would 
indicate less than optimal performance.  The PPT was used in this study to determine if any 
unreported motor, sensory or cognitive problems were affecting the patient’s physical function.  
The PPT 9-item test has been shown to demonstrate internal consistency (Cronbach’s alpha = 
.87) and interrater reliability (r = .99).122  It has also demonstrated concurrent validity with other 
functional performance measures such as the Katz ADL scale.128 
Data Analysis 
 
Descriptives were collected on the demographic data of the patients, their medications, 
comorbidities and the 9-item and 7-item PPT.  Analysis of variance (ANOVA) was used to 
determine if there were significant differences between the 6 patient groups based on severity of 
disease and unilateral vs. bilateral involvement, and also on laterality of the disease, left side vs. 
right side vs. both sides involved. 
 
The mean 9-item and 7-item PPT scores were calculated and compared to the maximum scores 
of 36/36 and 28/28 respectively.  A lower score indicated that a person needs more time to 
complete a task on the PPT, thus suggesting the beginning of  physical decline, and possibly 
preclinical disability.124,140  
 
Pearson correlation coefficients were calculated between the PPT scores and the number of 
comorbidities that a patient had, and also with the number of medications that a patient was 
taking.  
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Results 
 
Thirty-nine patients with asymptomatic carotid artery disease were tested.  Table 23 includes the 
basic demographics regarding these patients. 
Table 23:  Diagnostic Groups by Gender, Age and Side Affected in Patients with Asymptomatic 
Carotid Artery Disease. 
Diagnostic Group 
(n and % of total sample) 
Gender 
(n and % of total sample) 
Mean Age 
(yrs.) ±  S.D. 
Age 
Range 
(years) 
Side 
Involved 
(R=right 
     L=left 
     B=both) 
Unilateral Stenosis 
Moderate 
n = 3, (7.7%) 
2 male    (67%) 
1 female (33%) 
78  ± 6 71-83 2 – R 
1 – L 
Unilateral Stenosis  
Severe 
n = 18, (46.2%) 
11 male  (61%) 
7 female (39%) 
75  ± 8 55-87 6 – R 
8 - L 
Unilateral occlusion 
n = 3, (7.7%) 
2 male    (67%) 
1 female (33%) 
63  ± 16 48-79 2 – R 
1 - L 
Bilateral Stenosis 
Moderate 
n = 4, (10.3 %) 
3 male    (75%) 
1 female (25%) 
76  ± 8 66-85 2 – L 
2 – B 
Bilateral Stenosis  
Severe  
n = 9, (23.1%) 
5 male    (56 %) 
4 female (44%) 
73  ± 5 64-79 1 – L 
8 - B 
Bilateral Occlusion 
n = 2, (5.1%) 
1 male    (50%) 
1 female (50%) 
63  ± 5 59-66 2 - B 
All Patients 
(n = 39) 
23 male    (59%) 
16 female (41%) 
73 ± 8   48-87 
years 
14 – R 
13 – L 
12 - B 
 
The sample was slightly dominant for males, with an average age of 73 years (range 48-87).  
Most patients (70%) tested in this study were severely stenotic, with another 13 % being 
occluded, and the remaining 17% had moderate carotid artery stenosis.   
 
Table 23 also reflects which side was involved for the patients.  Patients with bilateral 
involvement were grouped into the side of stenosis that the surgeon would be considering for 
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surgery.  For example, in a situation of mild or moderate stenosis on the left side, and severe 
stenosis on the right side, the patient was classified as having a right side that was involved.  In 
situations when the level of stenosis was the same, or occlusion existed bilaterally, then the 
patient was classified with bilateral disease.  In general for the 39 patients, there were 14 with 
right side involvement, 13 with left side involvement and 12 with bilateral involvement. 
 
The most common comorbidities that the patients had were hypertension (39%), 
hypercholesteremia (36%) diabetes mellitus (33%) coronary artery disease (31%), and cardiac 
arrhythmia (13%).  Amongst the 39 patients, there were a wide variety of medications being 
taken.  The most common categories of medications were the CNS agents which included 5 
different medications, the antihypertensives and the antilipemics.  The 2 most common 
medications were aspirin (54%), and the antilipemic Zocor (26%). 
 
In this study, physical performance was analyzed from two perspectives, the severity of carotid 
artery disease, and also from the perspective of differences in performance based on laterality of 
disease.  In order to determine differences between the severity groups of the patients, an 
analysis of variance (ANOVA) was completed.  With the 39 patients, there was not a 
significance difference between the groups (unilateral or bilateral moderate, severe disease, or 
occlusion) on any of the physical performance measures at a p<.05 level of significance.  
 
For the PPT (9-item), it was found that no patient reached a perfect score of 36/36.  For all 39 
patients, scores ranged from 19/36 – 30/36 with a mean score of 27/36 (Table 24). 
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Table 24:  Physical Performance Test (9-item) in Patients with Carotid Artery Disease. 
 Number of patients Mean score ± S.D. Range 
Occluded 5 26  ± 2 21-30 
Moderate Stenosis 7 24  ± 2 14-31 
Severe Stenosis 27 28  ± 1 19-34 
Total 39 27  ± 1 14-34 
 
No subject reached a perfect score on the 7-item PPT of 28/28.  The range of scores for these 
patient groups was 19/28-22/28 (Table 25). 
Table 25:  Physical Performance Test (7-item) in Patients with Carotid Artery Disease. 
 Number of patients Mean score ± S.D. Range 
Occluded 5 22  ± 2 19-24 
Moderate Stenosis 7 19  ± 3 14-24 
Severe Stenosis 27 22  ± 3 15-27 
Total 39 21  ± 3 14-27 
 
Another way to consider physical performance for these patients with carotid artery disease is to 
look for differences in function based on the side of brain involvement.  Thus, data of the 39 
patients was analyzed comparing the location of the lesion as being right, left or both sides 
involved.  In an ANOVA to determine if there were differences on the 9-item PPT between these 
3 groups, the finding was not significant.  The mean score for the right and left side involved was 
the same (28/36), and in the patients with bilateral involvement the mean score was 26/36.   
 
Pearson correlation coefficients were calculated to determine a relationship between the 
comorbidities and the medications of the patients and their performance on the the PPT (9-item 
and 7-item).  No significant correlations were found. 
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The Physical Performance Test individual tasks were also timed and recorded.  A detailed 
analysis of each of the timed items was conducted.  Table 26 is a summary of the items for all 
the patients tested.  
 
Table 26:  Physical Performance Timed Items for Patients with Asymptomatic Carotid Artery 
Disease. 
Descriptive Statistics 
 
( n = 39) 
 
Mean seconds ± S.D. 
 
Range 
 
 
Normal PPT time 
(for score= 4) 
 
Sentence writing 15.13 ±6  8.7 – 35.9 ≤10 sec 
Eating (simulated) 13.87± 3 9.3 –19.2 ≤10 sec 
Lifting a book 2.03± 1 .8  -7.5 ≤ 2 sec 
Put on jacket 14.17± 4 7.7 – 26.3 ≤10 sec 
Pick up penny 4.05± 4 1.8 – 26.7 ≤ 2 sec 
50’ Walk 15.93± 4 0 – 25.5 ≤15 sec 
Climb one flight stairs 7.28± 3 0 – 20.6 ≤ 5 sec 
 
Further analysis was conducted to see if there was a difference on any PPT item based on the 
severity of the carotid artery disease for the unilateral and bilateral moderate stenosis, unilateral 
and bilateral severe stenosis and unilateral and bilateral occlusion subgroups.  Mean scores, 
standard deviations and ranges of the PPT timed items are reported in Table 27. 
 
Table 27:  Physical Performance Results on Timed Items for Patients with Moderate, Severe 
Carotid Artery Stenosis or Occlusion. 
Item Group Mean ±S.D. Range 
Sentence writing Occluded     (n = 5) 16.5 ± 7  11.2 – 26.7
  Mod Stenosis    (n = 7) 16.4 ± 3 12.3 – 20.8
  Severe Stenosis  (n = 27) 14.5 ± 6 8.7 – 35.9
  Total     (n = 39) 15.1 ± 6 8.7 – 35.9
Eating (simulated) Occluded 12.3 ± 2  10.0 – 14.0
  Mod Stenosis 17.1 ± 3 13.2 – 19.1
  Severe Stenosis 13.4 ± 3 9.3 – 18.6
  Total 13.9 ± 3 9.3 – 19.2
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Lifting a book Occluded 3.2 ± 3 .79 – 7.5
  Mod Stenosis 1.8 ± .6 1.2 – 2.8
  Severe Stenosis 2.0 ± .9 .76 – 5.5
  Total 2.1 ± 1 .76 – 7.5
Putting on jacket Occluded 12.5 ± 3 8.1 – 16.2
  Mod Stenosis 16.4 ± 5 11.5 – 26.3
  Severe Stenosis 13.9 ± 4 7.7 – 22.8
  Total 14.2 ± 4 7.7 – 26.3
Pick up penny Occluded 2.6 ± .6 1.8 – 3.5
  Mod Stenosis 7.0 ± 9 2.5 – 26.7
  Severe Stenosis 3.6 ± 2 2.0 – 11.1
  Total 4.1 ± 4 1.8 – 26.7
50' Walk Occluded 17.9 ± 2 16.3 – 21.9
  Mod Stenosis 17.1 ± 4 12.7 – 25.5
  Severe Stenosis 15.3 ± 4 .00 – 24.5
  Total 15.9 ± 4 .00 – 25.5
Climb one flight stairs Occluded 8.0 ± 8 .00 – 20.6
  Mod Stenosis 6.7 ± 3 .00 – 10.0
  Severe Stenosis 7.3 ± 2 .00 – 11.9
 mod: moderate 
 
An ANOVA was done to determine if there were differences in time completion for the tasks 
between these 3 subgroups (Table 28). 
 
Table 28:  ANOVA Table for Between Group Differences for the Timed PPT Items, Based on 
Severity of Carotid Disease. 
ANOVA 
 
    
Sum of 
Squares df 
Mean 
Square F Sig. 
Sentence writing Between Groups 32.431 2 16.216 .513 .60
  Within Groups 1137.872 36 31.608   
  Total 1170.303 38     
Eating (simulated) Between Groups 90.320 2 45.160 7.540 .00*
  Within Groups 215.628 36 5.990   
  Total 305.948 38     
Lifting a book Between Groups 6.612 2 3.306 2.251 .12
  Within Groups 52.863 36 1.468   
  Total 59.475 38     
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Put on jacket Between Groups 52.083 2 26.042 1.683 .20
  Within Groups 557.148 36 15.476   
  Total 609.231 38     
Pick up penny Between Groups 79.269 2 39.635 2.549 .09
  Within Groups 559.865 36 15.552   
  Total 639.134 38     
50’ Walk Between Groups 39.254 2 19.627 1.242 .30
  Within Groups 568.935 36 15.804   
  Total 608.188 38     
Climb one flight stairs Between Groups 4.894 2 2.447 .214 .81
  Within Groups 411.347 36 11.426   
  Total 416.240 38     
* p<.05  
Simulated eating was the only item that was significantly different (p<.00) between the levels of 
severity.  Tukey post hoc comparisons revealed that the moderately stenotic group had a 
significantly slower time recorded than the severely stenotic and occluded groups.  There were 
no significant differences on timed item scores based on lesion location. 
Discussion: 
 
In persons with asymptomatic carotid artery stenosis and occlusion when clinically assessed by 
the PPT, patients perform below the optimal standard on the 9-item and 7-item tests.  
Additionally, those with moderate stenosis (50-69%) performed the worst, with an average 9-
item PPT score of 24/36 and 7-item of 19/28.  When comparing these scores to the percentile 
rankings established for community-dwelling older adults (65 years and older, this study’s 
average age 73 years),148on the 9-item PPT, the average score for the moderate stenosis group 
placed them in approximately the 50th percentile of physical function, the severe stenosis group 
scored 28/36 placing them just below the 75th percentile of physical function, and the occluded 
group scored 26/36 placing them at approximately the 60th percentile of physical function.122  On 
the 7-item test, the percentiles were approximately the same, with the exception of the occluded 
group increasing the percentile of function to 75th percentile on the 7-item PPT.122  The 7-item 
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PPT has also been shown to be an independent predictor of death, with the lower scores 
indicating poor performance.128  In this study, the results demonstrate that at all levels of carotid 
artery stenosis and occlusion tested, the patients demonstrated poor performance.  Brach et. al, in 
a study evaluating physical decline in community-dwelling older women defined clinical decline 
as scoring below 4 (the highest score) on each PPT item.124  Fried et.al. indicated that a score less 
than the maximal score would be significant for preclinical disability.140  In this study, all 
asymptomatic patients with carotid artery stenosis and occlusion demonstrated scores at least 
25% below optimal function.  Thus, it is suggested that all patients tested demonstrated a 
functional decline that might be associated with a demonstration of early clinical symptoms of 
carotid artery disease. 
 
However, it has also been suggested that the maximal score on the PPT may actually not be the 
standard for healthy normal subjects.  In unpublished data of 19 healthy normal subjects with a 
mean age of 68 years, the mean 9 item PPT score was 30/36.135  The researchers have suggested 
that the maximal score may be an unrealistic expectation for the normal population.  The results 
of the asymptomatic patients with carotid artery disease remain below the 30/36 score as well.  
 
The PPT scores when analyzed from the perspective of laterality of disease revealed the same 
finding of a potential status of preclinical disability, with the score of 28/36 (75th percentile) if 
either the right or the left side was the affected artery, and 26/36 (60th percentile) when both 
sides were involved.  It was interesting to note that bilateral involvement led to a more impaired 
status.  This is a reasonable finding since impaired blood flow to both sides of the brain should 
affect function more profoundly. 
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In its design, the PPT items were chosen to indicate a level of difficulty for the item, and also 
reflect different dimensions of function, specifically upper fine motor function, upper coarse 
motor function, balance, coordination, mobility and endurance.122  In order to analyze the 
physical function of the patients in this study in more detail, an analysis of time to perform each 
task was done to determine if any task was significantly more difficult for any one group of 
patients.  More difficult in this case would imply taking a longer time to complete.   
 
When comparing the 3 subgroups of patients, the patients with moderate stenosis demonstrated a 
significant difference in time to complete the task simulated eating. This item has been identified 
as demonstrating a perceived minimal level of difficulty.122  The timed items also reflect a 
different functional dimension that the test was developed to assess, simulated eating tested 
upper fine motor function.149  An explanation for the deficit on this task might possibly be 
related to the patterns of blood flow and loss of blood flow to the brain as internal carotid artery 
stenosis might compromise the flow of blood to the areas of the brain responsible for the 
function of simulated eating.  The physiology of blood flow to the brain and compromise thereof 
remains an area of continued study.3,5,22  In cases of carotid artery occlusion, there is an increase 
in collateral blood supply from the opposite side of the brain that compensates for the lack of 
flow to the side of the brain fed by the occluded carotid artery.13  Additionally, Derdeyn et.al. 
found that asymptomatic patients with carotid artery occlusion were at a much lower risk of 
demonstrating an impaired hemodynamic state than patients with symptoms.4  However, this has 
only been researched in situations of carotid artery occlusion.  The data from this study 
demonstrated a functional decline in all asymptomatic patients, and a significant difference for a 
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particular task in the moderately stenotic patients.  No studies have been found that address the 
hemodynamic status of stenotic patients.  The detection of impaired functional performance 
might make us consider that these patients “are” symptomatic, with a status of preclinical 
disability.140  Further research is needed to assess the physiologic status of the blood flow in 
patients with carotid artery disease and the functional status, to determine if we might be 
“missing something” in our clinical assessment of these patients.         
Conclusion: 
 
The use of the PPT in patients with asymptomatic carotid artery stenosis and occlusion 
demonstrated less than optimal performance in all patient subgroups for both the 7-item and the 
9-item tests.  The time taken to perform the tasks on the tool was longer than the expected norm 
for the tool, which is an indication of preclinical disability.  Pre-clinical disability has been 
explained as a functional status that is a precursor to clinical functional impairment.  Therefore, 
in patients with asymptomatic carotid artery stenosis and occlusion, we conclude that they might 
not be asymptomatic, but are exhibiting changes in functional status that have not been routinely 
clinically identified or comprehended and communicated by the patient.  The authors suggest 
that a more detailed clinical assessment of the reportedly asymptomatic patients incorporating a 
functional measure might be useful in determining those patients who might be “symptomatic” 
and thus at an increased risk for stroke.  Ultimately, this could contribute to increasing stroke 
prevention by improving the identification of potentially symptomatic patients that have been 
currently unrecognized, resulting in more appropriate medical management for these patients. 
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Appendix A 
 
 
 
 
 
 
 
 
 
 
 
Repeatable Battery for the Assessment of Neuropsychological Status 
(RBANS) 
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Appendix B 
The Executive Interview (EXIT) 
 
NUMBER-LETTER TASK 
 
1. “I’d like you to say some numbers and letters for me like this.  1-A, 2-B, 3-what 
would come next?”________ 
 
“Now you try it starting with the number 1.  Keep going until I say ‘stop’.” 
1 2 3 4 5 
A B C D E “STOP” ________ 
 
Score:  0 = No errors 
   1 = Complete task with prompting (or repeat instructions) 
   2 = Doesn’t complete task. 
 
WORD FLUENCY 
 
2. “I am going to give you a letter.  You will have one minute to name as many words 
as you can think of which begin with that letter.  For example, with the letter ‘P’ 
you could say ‘people, pot, plant. . .’ and so on.  Give rule about proper nouns and 
using same word with a different ending.  For example, big, bigger, biggest.  Are you 
ready?  Do you have any questions?  The letter is A---GO!”  * mark off 15” 
increments* 
 
Score:  0 = 10 or more words 
   1 = 5 – 9 words 
   2 = Less than 5 words 
 
DESIGN FLUENCY 
 
3. “Look at these pictures.  Each is made with only four lines.  I am going to give you 
one minute to draw as many DIFFERENT designs as you can.  The only rules are 
that they must each be different and be drawn with four lines.  Now go.”  (Correct 
figures can contain curves.) 
 
Score:  0 = 10 more unique drawings, no copies of examples 
   1 = 5 – 9 unique drawings 
   2 = Less than 5 unique drawings 
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2. Mary fed a little lamb. 
3. A stitch in time saves lives. 
4. Tinkle, tinkle little star. 
5. A  B  C  D  U  F  G 
 
Score:  0 = No errors 
   1 = Fails to make one or more changes 
2 = Continues with one or more expressions (e.g.  Mary had a little lamb 
whose fleece was white as snow.) 
________________________________________________________________________ 
 
THEMATIC PERCEPTION 
 
5. Patient shown picture by examiner.  “Tell me what is happening in this picture.” 
 
Score:  0 = Tells spontaneous story (story=setting, 3 characters, action) 
   1 = Tells story with prompting x1 (anything else?) 
   2 = Fails to tell story despite prompt 
 *score 2 if not a clear story  
 
MEMORY/DISTRACTION TASK 
 
6. “Remember these three words – BOOK, TREE, HOUSE.”  (Patient repeats till all 
three words registered. (# trails = ________) 
“Remember them—I’ll ask you to repeat them for me later.” 
“Now—spell CAT for me . . .” ________ 
“Good.  Now spell it backwards.” ________ 
 “OK.  Tell me those three words we learned.” ________ 
 
Score: 0 = Patient names some or all of the three words correctly without naming 
‘cat’ (examiner may prompt “anything else?”) 
   1 = Other response ________________________________ 
  2 = Patient names ‘cat’ as one of the three words (perseveration)  
 
INTERFERENCE TASK 
 
7. “What color are these letters?”  (SWEEP hand back and forth over letters) 
 
Score:  0 = black 
   1 = brown (repeat question x1) then black 
  2 = brown (prompt) brown (intrusion)  
 
ANOMALOUS SENTENCE REPETITION 
 
4. “Listen carefully and repeat these sentences exactly.”  (Read sentences in a neutral 
tone.) 
 
1. I pledge allegiance to those flags. 
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8. “Please hold your hands forward, palms down.  Relax while I check your reflexes.”  
(Rotate arms one at a time at the elbow as if to check for cogwheeling.  Gauge patient’s 
active participation/anticipation of rotation.) 
 
Score:  0 = Patient remains passive. 
   1 = Equivocal  re: passive vs. active 
2 = patient actively copies the circular motion (Mihelten) or resists 
(Gegenhalten)  
 
AUTOMATIC BEHAVIOR II 
 
9. “Please hold your hands out palms UP.  Just relax.”  (Examiner pushes down on 
patient’s hands-gently at first, becoming more forceful.  Gauge patient’s active 
participation in response.) 
 
Score:  0 = Patient offers no resistance (remains passive) 
   1 = Equivocal  re: passive vs. active 
  2 = Actively resists or complies with examiner 
 
 
__________________________________________________________________ 
GRASP REFLEX 
 
10. “Please hold your hands out with open palms down.  Just relax.”  (Both palms are 
lightly stroked simultaneously by the examiner, who looks for grasping/gripping actions 
in the fingers.) 
 
Score:  0 = Absent. 
   1 = Equivocal 
  2 = Present 
 
  Patient grasps firmly enough to be drawn up and out of chair by examiner.  
 
SOCIAL HABIT I 
 
11. Fix subject’s eyes.  Silently count to three while maintaining subject’s gaze, then say 
“Thank you.” 
 
Score: 0 = Replies with a question (e.g.  Thank you for what?) or says nothing. 
   1 = Other response  
  2 = “You’re welcome”  
 
AUTOMATIC BEHAVIOR I 
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Score:  0 = Completes task spontaneously. 
   1 = Completes task with examiner modeling task for patient. 
  2 = Fails task despite modeling by examiner. 
 
SNOUT REFLEX 
 
13. “Just relax.”  (Examiner slowly brings index finger toward patient’s lips, pausing 
momentarily 2” away.  Finger is then placed vertically across lips and then is lightly 
tapped with the other hand.  Observe lips for puckering.) 
 
Score:  0 = Not present 
   1 = Equivocal 
  2 = Present  
 
FINGER-NOSE-FINGER TASK 
 
14. (Hold up index finger.)  “Touch my finger.”  (Leave finger in place.)  “Now touch your 
nose.” 
 
Score:  0 = Complies, using same hand. 
   1 = Other response  
2 = Complies, using other hand while continuing to touch examiner’s 
finger. 
________________________________________________________________________ 
GO/NO-GO TASK 
 
15. “Now . . . When I touch my nose, you raise your finger like this.”  (Raise index 
finger.)  “When I raise my finger, you touch your nose like this.”  (Touch nose with 
index finger.)  Have patient repeat instructions if possible.  Examiner begins task.  Leave 
finger in place while awaiting patient’s response.  Give directions up to three times.  
Repeat directions when error occurs. 
Examiner    Patient 
       F     N     F 
       N     F     N 
       F     N     F 
       F     N     F 
       N     F     N 
 
Score:  0 = Performs sequence correctly. 
   1 = Correct, requires prompting/repeating instructions. 
  2 = Fails sequence despite prompting.repeat instructions. 
 
MOTOR IMPERSISTENCE 
 
12. “Stick out your tongue and say ‘aah’ until I say stop . . . GO!”  (Count to three 
silently.)  (Subject must sustain a constant tone, not “ah . . ah . . ah”) 
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16. “Now listen carefully.  I want you to do exactly what I say.  Ready?  Touch your 
ear.”  (Examiner touches nose and keeps finger there.) 
 
Score:  0 = Touches ear. 
1 = Other response _________________________ (Look for mid-position 
stance.) 
  2 = Touches nose.  
 
LURIA HAND SEQUENCE I 
 
17. “Can you do this?”  (Invite patient to watch while alternating palm/fist with either hand.  
Once patient begins, ask to “Keep going” while examiner stops.  Count # of successive 
palm/fist cycles.) 
 
Score:  0 = 4 cycles without errors after examiner stops. 
1 = 4 cycles with additional verbal prompt (“keep going”) or modeling. 
2 = Unsuccessful despite prompting/modeling (watch for mid-position 
stances.)  
 
LURIA HAND SEQUENCE II 
 
18. “Can you do this?”  (Examiner models SLAP, FIST, CUT – while patient imitates each 
step).  “Now follow me.”  (Examiner begins to repeat sequence.)  “Keep doing this until 
I say stop.”  (Examiner stops.) 
 
Score:  0 = 3 cycles without error after examiner stops. 
1 = 3 cycles with additional verbal prompt (“keep going”) or modeling. 
  2 = Unsuccessful.  
________________________________________________________________________ 
GRIP TASK 
 
19. “Squeeze my fingers.”  (With both hands, form a pistol.) 
 
Score:  0 = Patient grips fingers. 
   1 = Other response _________________________ 
  2 = Pulls examiner’s hands together.  
 
 
ECHOPRAXIA II 
 
20. (Suddenly and without warning, the examiner slaps his hands together while facing the 
patient.) 
 
Score:  0 = Does not imitate examiner. 
   1 = Hesitates, uncertain. 
  2 = Imitates slap.  
ECHOPRAXIA I 
 
  113 
 
COMPLEX COMMAND TASK 
 
21. “Put your left hand on top of you head and close your eyes.  That was good.”  
(Examiner remains aloof, begins next task.) 
 
Score:  0 = Stops when next task began. 
   1 = Equivocal = holds posture during part of next task. 
2 = Maintains posture through completion of next task—has to be told to 
cease. 
(Quickly go on to next task.) 
 
SERIAL ORDER REVERSAL TASK 
 
22. (Have patient recite the months of the year.)  “Now start with January and say them 
all backwards . . .” 
 
Score:  0 = No errors, at least past September. 
1 = Get past September but requires repeat instructions (“Just start with 
January and say them all backwards.”) 
  2 = Can’t succeed despite prompting. 
 
COUNTING TASK 
 
23. (Examiner taps each picture around the figure in a clockwise direction.)  “Please count 
the fish in this picture out loud.” 
 
Score:  0 = 4 
   1 = Less than 4. 
  2 = More than 4.  
*  Perseveration means 2 or more full circuits. 
 
 
 
 
              
UTILIZATION BEHAVIOR 
 
24. (Examiner holds pen near point and dramatically “presents” it to patient asking:)  “What 
is this called?” 
 
Score:  0 = “pen” 
   1 = Reaches, hesitates. 
  2 = Takes pen from examiner (utilization behavior). 
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25. (Examiner flexes wrist up and down and points to it asking:)  “What is this called?” 
 
Score:  0 = “wrist” 
   1 = Other response _________________________ 
  2 = Flexes wrist up and down (echopraxia).  
 
IMITATION BEHAVIOR 
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Appendix C 
Physical Performance Test 
              
         Physical Performance Test__  
          Time  Scoring  Score_ 
 
1.  Write a sentence (Whales live in the blue ocean) ______sec* < 10 sec = 4 
         10.5 - 15 sec = 3 
         15.5 - 20 sec = 2 
         >20 sec = 1 
unable = 0 
 
2.  Simulated eating     ______sec* < 10 sec = 4 
         10.5 - 15 sec = 3 
         15.5 - 20 sec = 2 
         >20 sec = 1 
         unable = 0 
 
3.  Lift a book and put it on a shelf   _____sec* < 2 sec = 4 
         2.5 - 4 sec = 3 
         4.5 - 6 sec = 2 
         >6 sec = 1 
         unable = 0 
 
4.  Put on and remove a jacket    ______sec* < 10 sec = 4 
         10.5 - 15 sec = 3 
         15.5 - 20 sec = 2 
         >20 sec = 1 
         unable = 0 
 
5.  Pick up penny from floor    ______sec* < 2 sec = 4 
         2.5 - 4 sec = 3 
         4.5 - 6 sec = 2 
         >6 sec = 1 
         unable = 0 
 
6.  Turn 360 degrees     discontinuous steps  0 
       continuous steps  2 
       unsteady (grabs, staggers) 0 
steady    2 
 
7.  50-foot walk test     ______sec* < 10 sec = 4 
         10.5 - 15 sec = 3 
         15.5 - 20 sec = 2 
         >20 sec = 1 
         unable = 0 
 
8.  Climb one flight of stairs **    ______sec* < 5 sec = 4 
         5.5 - 10 sec = 3 
         10.5 - 15 sec = 2 
         >15 sec = 1 
         unable = 0 
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9.  Climb stairs **     Number of flights of stairs up _____ 
and down (maximum 4). 
 
TOTAL SCORE (maximum 36 for nine-item, 28 for seven-item)   ______ nine-item 
          ______ seven-item 
  *  For timed measurements, round to nearest 0.5 seconds.        **  Omit for seven-item 
scoring. 
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Appendix D 
Instrumental Activities of Daily Living (Lawton IADL)* 
 
INSTRUCTIONS:  Use the prompt cards when asking the patient these questions. 
 
1. Can you use the phone: 
01 completely unable to use the phone 
02 with some help 
03 without help 
 
2. Can you get to places out of walking distance: 
01 completely unable to travel unless special arrangements are made 
02 with some help 
03 without help 
 
3. Can you go shopping for groceries: 
01 Completely unable to do any shopping 
02 With some help 
03 Without help 
 
4. Can you prepare your own meals: 
01 Completely unable to prepare meals 
02 With some help 
03 Without help 
 
5. Can you do your own housework: 
01 completely unable to do any housework 
02 with some help 
03 without help 
 
6. Can you do your own handyman work? 
01 Completely unable to do any handyman work 
02 With some help 
03 Without help 
 
7. Can you do your own laundry: 
01 completely unable to do any laundry at all 
02 with some help 
03 without help 
 
8. A.  Do you take medicines or use any medications? 
01 Yes (Go to question 8B.) 
02 No (Go to question 8C.) 
B. Do you take your own medicine: 
01 completely unable to take own medicine 
02 with some help (if someone prepares it or reminds you) 
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03 without help (in the right doses at the right time) 
C. If you had to take medicine, could you do it: 
01 completely unable to take own medicine 
02 with some help (if someone prepares it or reminds you) 
03 without help (in the right doses at the right time) 
 
9. Can you manage your own money:     
01 completely unable to manage own money 
02 with some help 
03 without help 
 
 
TOTAL IADL:  ____________ 
 
From Lawton MP:  Assessing the competence of older people.  In Kent D, Kastenbaum R, 
Sherwood S (eds): Research Planning and Action for the Elderly.  New York, Behavioral 
Publications, 1972. 
